{"status": "ok", "message-type": "work-list", "message-version": "1.0.0", "message": {"facets": {}, "total-results": 429250, "items": [{"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T07:39:48Z", "timestamp": 1574149188276}, "reference-count": 33, "publisher": "American Society of Hematology", "issue": "9", "content-domain": {"domain": ["ashpublications.org"], "crossmark-restriction": true}, "published-print": {"date-parts": [[2003, 5, 1]]}, "abstract": "<jats:p>Promyelocytic leukemia protein PML acts as a tumor suppressor, whereas its chimeric mutant promyelocytic leukemia/retinoic acid receptor\u03b1 (PML/RAR\u03b1) causes acute promyelocytic leukemia (APL). Because PML has been shown to form transcription-regulatory complexes with various molecules, we speculated that PML and/or PML/RAR\u03b1 might affect signal transducer and activator of transcription 3 (STAT3) activity, which plays a crucial role in granulocyte colony-stimulating factor (G-CSF)\u2013induced growth and survival of myeloid cells. In luciferase assays, PML inhibited STAT3 activity in NIH3T3, 293T, HepG2, and 32D cells. PML formed a complex with STAT3 through B-box and COOH terminal regions in vitro and in vivo, thereby inhibiting its DNA binding activity. Although PML/RAR\u03b1 did not interact with STAT3, it dissociated PML from STAT3 and restored its activity suppressed by PML. To assess the biologic significance of these findings, we introduced PML and PML/RAR\u03b1 into interleukin-3 (IL-3)\u2013dependent Ba/F3 cells expressing the chimeric receptor composed of extracellular domain of G-CSF-R and cytoplasmic domain of gp130, in which gp130-mediated growth is essentially dependent on STAT3 activity. Neither PML nor PML/RAR\u03b1 affected IL-3\u2013dependent growth of these clones. By contrast, gp130-mediated growth was abrogated by PML, whereas it was enhanced by PML/RAR\u03b1. These results reveal new functions of PML and PML/RAR\u03b1 and suggest that dysregulated STAT3 activity by PML/RAR\u03b1 may participate in the pathogenesis of APL.</jats:p>", "DOI": "10.1182/blood-2002-08-2474", "type": "journal-article", "created": {"date-parts": [[2003, 4, 21]], "date-time": "2003-04-21T17:30:06Z", "timestamp": 1050946206000}, "page": "3668-3673", "update-policy": "http://dx.doi.org/10.1182/blood.2019cm0000", "source": "Crossref", "is-referenced-by-count": 23, "title": ["Opposing effects of PML and PML/RAR\u03b1 on STAT3 activity"], "prefix": "10.1182", "volume": "101", "author": [{"given": "Akira", "family": "Kawasaki", "sequence": "first", "affiliation": [{"name": "From the Department of Hematology and Oncology, Osaka University Graduate School of Medicine; and the Department of Immunology, Osaka City University Medical School, Osaka, Japan."}]}, {"given": "Itaru", "family": "Matsumura", "sequence": "additional", "affiliation": [{"name": "From the Department of Hematology and Oncology, Osaka University Graduate School of Medicine; and the Department of Immunology, Osaka City University Medical School, Osaka, Japan."}]}, {"given": "Yoshihisa", "family": "Kataoka", "sequence": "additional", "affiliation": [{"name": "From the Department of Hematology and Oncology, Osaka University Graduate School of Medicine; and the Department of Immunology, Osaka City University Medical School, Osaka, Japan."}]}, {"given": "Eri", "family": "Takigawa", "sequence": "additional", "affiliation": [{"name": "From the Department of Hematology and Oncology, Osaka University Graduate School of Medicine; and the Department of Immunology, Osaka City University Medical School, Osaka, Japan."}]}, {"given": "Koichi", "family": "Nakajima", "sequence": "additional", "affiliation": [{"name": "From the Department of Hematology and Oncology, Osaka University Graduate School of Medicine; and the Department of Immunology, Osaka City University Medical School, Osaka, Japan."}]}, {"given": "Yuzuru", "family": "Kanakura", "sequence": "additional", "affiliation": [{"name": "From the Department of Hematology and Oncology, Osaka University Graduate School of Medicine; and the Department of Immunology, Osaka City University Medical School, Osaka, Japan."}]}], "member": "234", "reference": [{"key": "2019111821444278100_B1", "doi-asserted-by": "crossref", "first-page": "663", "DOI": "10.1016/0092-8674(91)90112-C", "article-title": "Chromosomal translocation t(15; 17) in human acute promyelocytic leukemia fuses RAR\u03b1 with a novel putative transcriptional factor, PML.", "volume": "66", "author": "Kakizuka", "year": "1991", "journal-title": "Cell."}, {"key": "2019111821444278100_B2", "doi-asserted-by": "crossref", "first-page": "675", "DOI": "10.1016/0092-8674(91)90113-D", "article-title": "The PML-RAR\u03b1 fusion mRNA generated by the t(15; 17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR.", "volume": "66", "author": "de The", "year": "1991", "journal-title": "Cell."}, {"key": "2019111821444278100_B3", "doi-asserted-by": "crossref", "first-page": "1601", "DOI": "10.1073/pnas.93.4.1601", "article-title": "In vivo and in vitro characterization of the B1 and B2 zinc binding domains from the acute promyelocytic leukemia proto-oncoprotein PML.", "volume": "93", "author": "Borden", "year": "1996", "journal-title": "Proc Natl Acad Sci U S A."}, {"key": "2019111821444278100_B4", "doi-asserted-by": "crossref", "first-page": "6858", "DOI": "10.1128/MCB.14.10.6858", "article-title": "PML, a growth suppressor disrupted in acute promyelocytic leukemia.", "volume": "14", "author": "Mu", "year": "1994", "journal-title": "Mol Cell Biol."}, {"key": "2019111821444278100_B5", "doi-asserted-by": "crossref", "first-page": "1073", "DOI": "10.1002/j.1460-2075.1994.tb06356.x", "article-title": "The t(15;17) translocation alters a nuclear body in a retinoic acid-reversible fashion.", "volume": "14", "author": "Koken", "year": "1994", "journal-title": "EMBO J."}, {"key": "2019111821444278100_B6", "doi-asserted-by": "crossref", "first-page": "1084", "DOI": "10.1128/MCB.18.2.1084", "article-title": "The promyelocytic leukemia gene product (PML) forms stable complexes with the retinoblastoma protein.", "volume": "18", "author": "Alcalay", "year": "1998", "journal-title": "Mol Cell Biol."}, {"key": "2019111821444278100_B7", "doi-asserted-by": "crossref", "first-page": "207", "DOI": "10.1038/35018127", "article-title": "PML regulates p53 acetylation and premature senescence induced by oncogenic Ras.", "volume": "406", "author": "Pearson", "year": "2000", "journal-title": "Nature."}, {"key": "2019111821444278100_B8", "doi-asserted-by": "crossref", "first-page": "730", "DOI": "10.1038/35036365", "article-title": "The function of PML in p53-dependent apoptosis.", "volume": "2", "author": "Guo", "year": "2000", "journal-title": "Nat Cell Biol."}, {"key": "2019111821444278100_B9", "first-page": "2015", "article-title": "PML is induced by oncogenic ras and promotes premature senescence.", "volume": "14", "author": "Ferbeyre", "year": "2000", "journal-title": "Genes Dev."}, {"key": "2019111821444278100_B10", "doi-asserted-by": "crossref", "first-page": "7216", "DOI": "10.1038/sj.onc.1204855", "article-title": "The theory of APL.", "volume": "20", "author": "Piazza", "year": "2001", "journal-title": "Oncogene."}, {"key": "2019111821444278100_B11", "doi-asserted-by": "crossref", "first-page": "1547", "DOI": "10.1126/science.279.5356.1547", "article-title": "Role of PML in cell growth and the retinoic acid pathway.", "volume": "279", "author": "Wang", "year": "1998", "journal-title": "Science."}, {"key": "2019111821444278100_B12", "doi-asserted-by": "crossref", "first-page": "629", "DOI": "10.1002/j.1460-2075.1992.tb05095.x", "article-title": "Structure, localization and transcriptional properties of two classes of retinoic acid receptor \u03b1 fusion proteins in acute promyelocytic leukemia (APL): structural similarities with a new family of oncoproteins.", "volume": "11", "author": "Kastner", "year": "1992", "journal-title": "EMBO J."}, {"key": "2019111821444278100_B13", "doi-asserted-by": "crossref", "first-page": "266", "DOI": "10.1038/3073", "article-title": "PML is essential for multiple apoptotic pathways.", "volume": "20", "author": "Wang", "year": "1998", "journal-title": "Nature Genet."}, {"key": "2019111821444278100_B14", "doi-asserted-by": "crossref", "first-page": "259", "DOI": "10.1038/3068", "article-title": "PML induces a novel caspase-independent death process.", "volume": "20", "author": "Quignon", "year": "1998", "journal-title": "Nature Genet."}, {"key": "2019111821444278100_B15", "doi-asserted-by": "crossref", "first-page": "2612", "DOI": "10.1038/sj.onc.1203477", "article-title": "Control of myeloid differentiation and survival by Stats.", "volume": "19", "author": "Smithgall", "year": "2000", "journal-title": "Oncogene."}, {"key": "2019111821444278100_B16", "doi-asserted-by": "crossref", "first-page": "2474", "DOI": "10.1038/sj.onc.1203527", "article-title": "STATs in oncogenesis.", "volume": "19", "author": "Bowman", "year": "2000", "journal-title": "Oncogene."}, {"key": "2019111821444278100_B17", "doi-asserted-by": "crossref", "first-page": "2494", "DOI": "10.1038/sj.onc.1203486", "article-title": "STAT signaling in the pathogenesis and treatment of leukemias.", "volume": "19", "author": "Lin", "year": "2000", "journal-title": "Oncogene."}, {"key": "2019111821444278100_B18", "doi-asserted-by": "crossref", "first-page": "2511", "DOI": "10.1038/sj.onc.1203479", "article-title": "The role of STATs in myeloid differentiation and leukemia.", "volume": "19", "author": "Coffer", "year": "2000", "journal-title": "Oncogene."}, {"key": "2019111821444278100_B19", "doi-asserted-by": "crossref", "first-page": "193", "DOI": "10.1016/S1074-7613(01)00101-7", "article-title": "STAT-3 activation is required for normal G-CSF-dependent proliferation and granulocytic differentiation.", "volume": "14", "author": "McLemore", "year": "2001", "journal-title": "Immunity."}, {"key": "2019111821444278100_B20", "doi-asserted-by": "crossref", "first-page": "25184", "DOI": "10.1074/jbc.272.40.25184", "article-title": "Involvement of STAT3 in the granulocyte colony-stimulating factor-induced differentiation of myeloid cells.", "volume": "272", "author": "Shimozaki", "year": "1997", "journal-title": "J Biol Chem."}, {"key": "2019111821444278100_B21", "doi-asserted-by": "crossref", "first-page": "63", "DOI": "10.1084/jem.189.1.63", "article-title": "STAT3 is required for the gp130-mediated full activation of the c-myc gene.", "volume": "189", "author": "Kiuchi", "year": "1999", "journal-title": "J Exp Med."}, {"key": "2019111821444278100_B22", "doi-asserted-by": "crossref", "first-page": "703", "DOI": "10.1182/blood.V86.2.703.bloodjournal862703", "article-title": "Growth response of acute myeloblastic leukemia cells to recombinant human thrombopoietin.", "volume": "86", "author": "Matsumura", "year": "1995", "journal-title": "Blood."}, {"key": "2019111821444278100_B23", "doi-asserted-by": "crossref", "first-page": "1367", "DOI": "10.1093/emboj/18.5.1367", "article-title": "Transcriptional regulation of the cyclin D1 promoter by STAT5: its involvement in cytokine-dependent growth of hematopoietic cells.", "volume": "18", "author": "Matsumura", "year": "1999", "journal-title": "EMBO J."}, {"key": "2019111821444278100_B24", "doi-asserted-by": "crossref", "first-page": "3651", "DOI": "10.1002/j.1460-2075.1996.tb00734.x", "article-title": "A central role for Stat3 in IL-6-induced regulation of growth and differentiation in M1 leukemia cells.", "volume": "15", "author": "Nakajima", "year": "1996", "journal-title": "EMBO J."}, {"key": "2019111821444278100_B25", "doi-asserted-by": "crossref", "first-page": "4282", "DOI": "10.1128/MCB.18.7.4282", "article-title": "Involvement of prolonged ras activation in thrombopoietin-induced megakaryocytic differentiation of a human factor-dependent hematopoietic cell line.", "volume": "18", "author": "Matsumura", "year": "1998", "journal-title": "Mol Cell Biol."}, {"key": "2019111821444278100_B26", "doi-asserted-by": "crossref", "first-page": "1601", "DOI": "10.1073/pnas.93.4.1601", "article-title": "In vivo and in vitro characterization of the B1 and B2 zinc-binding domains from the acute promyelocytic leukemia protooncoprotein PML.", "volume": "93", "author": "Borden", "year": "1996", "journal-title": "Proc Natl Acad Sci U S A."}, {"key": "2019111821444278100_B27", "doi-asserted-by": "crossref", "first-page": "479", "DOI": "10.1126/science.284.5413.479", "article-title": "Synergistic signaling in fetal brain by STAT3-Smad1 complex bridged by p300.", "volume": "284", "author": "Nakashima", "year": "1999", "journal-title": "Science."}, {"key": "2019111821444278100_B28", "doi-asserted-by": "crossref", "first-page": "7138", "DOI": "10.1128/MCB.19.10.7138", "article-title": "Interacting regions in Stat3 and c-Jun that participate in cooperative transcriptional activation.", "volume": "19", "author": "Zhang", "year": "1999", "journal-title": "Mol Cell Biol."}, {"key": "2019111821444278100_B29", "doi-asserted-by": "crossref", "first-page": "2553", "DOI": "10.1128/MCB.18.5.2553", "article-title": "Stat3 activation is required for cellular transformation by v-src.", "volume": "18", "author": "Bromberg", "year": "1998", "journal-title": "Mol Cell Biol."}, {"key": "2019111821444278100_B30", "doi-asserted-by": "crossref", "first-page": "2637", "DOI": "10.1182/blood.V99.8.2637", "article-title": "Interactions of STAT5b-RARalpha, a novel acute promyelocytic leukemia fusion protein, with retinoic acid receptor and STAT3 signaling pathways.", "volume": "99", "author": "Dong", "year": "2002", "journal-title": "Blood."}, {"key": "2019111821444278100_B31", "doi-asserted-by": "crossref", "first-page": "24096", "DOI": "10.1074/jbc.M001606200", "article-title": "Full oncogenic activities of v-Src are mediated by multiple signaling pathways: Ras as an essential mediator for cell survival.", "volume": "275", "author": "Odajima", "year": "2000", "journal-title": "J Biol Chem."}, {"key": "2019111821444278100_B32", "doi-asserted-by": "crossref", "first-page": "295", "DOI": "10.1016/S0092-8674(00)81959-5", "article-title": "Stat3 as an oncogene.", "volume": "98", "author": "Bromberg", "year": "1999", "journal-title": "Cell."}, {"key": "2019111821444278100_B33", "doi-asserted-by": "crossref", "first-page": "5302", "DOI": "10.1073/pnas.94.10.5302", "article-title": "Acute leukemia with promyelocytic features in PML/RARalpha transgenic mice.", "volume": "94", "author": "He", "year": "1997", "journal-title": "Proc Natl Acad Sci U S A."}], "container-title": ["Blood"], "language": "en", "link": [{"URL": "http://ashpublications.org/blood/article-pdf/101/9/3668/1256761/h80903003668.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "syndication"}, {"URL": "http://ashpublications.org/blood/article-pdf/101/9/3668/1256761/h80903003668.pdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T02:44:57Z", "timestamp": 1574131497000}, "score": 57.78855, "issued": {"date-parts": [[2003, 5, 1]]}, "references-count": 33, "journal-issue": {"published-print": {"date-parts": [[2003, 5, 1]]}, "issue": "9"}, "URL": "http://dx.doi.org/10.1182/blood-2002-08-2474", "relation": {"cites": []}, "ISSN": ["1528-0020", "0006-4971"], "issn-type": [{"value": "0006-4971", "type": "print"}, {"value": "1528-0020", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T17:21:43Z", "timestamp": 1574875303845}, "reference-count": 0, "publisher": "Wiley", "issue": "4", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[1992, 4, 1]], "date-time": "1992-04-01T00:00:00Z", "timestamp": 702086400000}, "delay-in-days": 0, "content-version": "tdm"}, {"URL": "http://onlinelibrary.wiley.com/termsAndConditions#vor", "start": {"date-parts": [[1992, 4, 1]], "date-time": "1992-04-01T00:00:00Z", "timestamp": 702086400000}, "delay-in-days": 0, "content-version": "vor"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["The EMBO Journal"], "published-print": {"date-parts": [[1992, 4]]}, "DOI": "10.1002/j.1460-2075.1992.tb05185.x", "type": "journal-article", "created": {"date-parts": [[2018, 9, 6]], "date-time": "2018-09-06T16:10:57Z", "timestamp": 1536250257000}, "page": "1397-1407", "source": "Crossref", "is-referenced-by-count": 146, "title": ["Genomic variability and alternative splicing generate multiple PML/RAR alpha transcripts that encode aberrant PML proteins and PML/RAR alpha isoforms in acute promyelocytic leukaemia."], "prefix": "10.1002", "volume": "11", "author": [{"given": "P.P.", "family": "Pandolfi", "sequence": "first", "affiliation": []}, {"given": "M.", "family": "Alcalay", "sequence": "additional", "affiliation": []}, {"given": "M.", "family": "Fagioli", "sequence": "additional", "affiliation": []}, {"given": "D.", "family": "Zangrilli", "sequence": "additional", "affiliation": []}, {"given": "A.", "family": "Mencarelli", "sequence": "additional", "affiliation": []}, {"given": "D.", "family": "Diverio", "sequence": "additional", "affiliation": []}, {"given": "A.", "family": "Biondi", "sequence": "additional", "affiliation": []}, {"given": "F.", "family": "Lo Coco", "sequence": "additional", "affiliation": []}, {"given": "A.", "family": "Rambaldi", "sequence": "additional", "affiliation": []}, {"given": "F.", "family": "Grignani", "sequence": "additional", "affiliation": []}], "member": "311", "published-online": {"date-parts": [[1992, 4, 1]]}, "container-title": ["The EMBO Journal"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fj.1460-2075.1992.tb05185.x", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://onlinelibrary.wiley.com/wol1/doi/10.1002/j.1460-2075.1992.tb05185.x/fullpdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 9, 6]], "date-time": "2018-09-06T16:11:26Z", "timestamp": 1536250286000}, "score": 49.12733, "issued": {"date-parts": [[1992, 4]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1992, 4]]}, "issue": "4"}, "URL": "http://dx.doi.org/10.1002/j.1460-2075.1992.tb05185.x", "archive": ["Portico"], "ISSN": ["0261-4189"], "issn-type": [{"value": "0261-4189", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 18]], "date-time": "2019-11-18T21:41:49Z", "timestamp": 1574113309421}, "reference-count": 0, "publisher": "The Endocrine Society", "issue": "12", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Molecular Endocrinology"], "published-print": {"date-parts": [[1995, 12, 1]]}, "DOI": "10.1210/me.9.12.1791", "type": "journal-article", "created": {"date-parts": [[2004, 2, 23]], "date-time": "2004-02-23T23:40:41Z", "timestamp": 1077579641000}, "page": "1791-1803", "source": "Crossref", "is-referenced-by-count": 20, "title": ["Effect of PML and PML-RAR on the transactivation properties and subcellular distribution of steroid hormone receptors"], "prefix": "10.1210", "volume": "9", "author": [{"given": "A.", "family": "Guiochon-Mantel", "sequence": "first", "affiliation": []}], "member": "80", "container-title": ["Molecular Endocrinology"], "language": "en", "link": [{"URL": "http://press.endocrine.org/doi/full/10.1210/mend.9.12.8614415", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 2]], "date-time": "2016-12-02T23:03:10Z", "timestamp": 1480719790000}, "score": 39.937195, "issued": {"date-parts": [[1995, 12, 1]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1995, 12, 1]]}, "issue": "12"}, "URL": "http://dx.doi.org/10.1210/me.9.12.1791", "ISSN": ["0888-8809"], "issn-type": [{"value": "0888-8809", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 5]], "date-time": "2019-12-05T07:19:42Z", "timestamp": 1575530382917}, "reference-count": 0, "publisher": "American Society of Hematology", "issue": "8", "content-domain": {"domain": ["ashpublications.org"], "crossmark-restriction": true}, "published-print": {"date-parts": [[1993, 4, 15]]}, "DOI": "10.1182/blood.v81.8.2210.bloodjournal8182210", "type": "journal-article", "created": {"date-parts": [[2019, 10, 13]], "date-time": "2019-10-13T09:06:31Z", "timestamp": 1570957591000}, "page": "2210-2211", "update-policy": "http://dx.doi.org/10.1182/blood.2019cm0000", "source": "Crossref", "is-referenced-by-count": 0, "title": ["CD2 expression and the PML-RAR gene [letter; comment]"], "prefix": "10.1182", "volume": "81", "author": [{"given": "D", "family": "Claxton", "sequence": "first", "affiliation": []}, {"given": "C", "family": "Reading", "sequence": "additional", "affiliation": []}, {"given": "A", "family": "Deisseroth", "sequence": "additional", "affiliation": []}], "member": "234", "container-title": ["Blood"], "language": "en", "link": [{"URL": "http://ashpublications.org/blood/article-pdf/81/8/2210/228225/2210.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "syndication"}, {"URL": "http://ashpublications.org/blood/article-pdf/81/8/2210/228225/2210.pdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T04:06:25Z", "timestamp": 1574222785000}, "score": 36.42254, "issued": {"date-parts": [[1993, 4, 15]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1993, 4, 15]]}, "issue": "8"}, "URL": "http://dx.doi.org/10.1182/blood.v81.8.2210.bloodjournal8182210", "ISSN": ["0006-4971", "1528-0020"], "issn-type": [{"value": "0006-4971", "type": "print"}, {"value": "1528-0020", "type": "electronic"}], "subject": ["Immunology", "Cell Biology", "Biochemistry", "Hematology"]}, {"indexed": {"date-parts": [[2019, 12, 5]], "date-time": "2019-12-05T07:25:06Z", "timestamp": 1575530706281}, "reference-count": 0, "publisher": "American Society of Hematology", "issue": "8", "content-domain": {"domain": ["ashpublications.org"], "crossmark-restriction": true}, "published-print": {"date-parts": [[1993, 4, 15]]}, "DOI": "10.1182/blood.v81.8.2210.2210", "type": "journal-article", "created": {"date-parts": [[2019, 10, 13]], "date-time": "2019-10-13T20:17:10Z", "timestamp": 1570997830000}, "page": "2210-2211", "update-policy": "http://dx.doi.org/10.1182/blood.2019cm0000", "source": "Crossref", "is-referenced-by-count": 0, "title": ["CD2 expression and the PML-RAR gene [letter; comment]"], "prefix": "10.1182", "volume": "81", "author": [{"given": "D", "family": "Claxton", "sequence": "first", "affiliation": []}, {"given": "C", "family": "Reading", "sequence": "additional", "affiliation": []}, {"given": "A", "family": "Deisseroth", "sequence": "additional", "affiliation": []}], "member": "234", "container-title": ["Blood"], "language": "en", "link": [{"URL": "http://ashpublications.org/blood/article-pdf/81/8/2210/609361/2210.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "syndication"}, {"URL": "http://ashpublications.org/blood/article-pdf/81/8/2210/609361/2210.pdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T06:32:50Z", "timestamp": 1574231570000}, "score": 36.42254, "issued": {"date-parts": [[1993, 4, 15]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1993, 4, 15]]}, "issue": "8"}, "URL": "http://dx.doi.org/10.1182/blood.v81.8.2210.2210", "ISSN": ["0006-4971", "1528-0020"], "issn-type": [{"value": "0006-4971", "type": "print"}, {"value": "1528-0020", "type": "electronic"}], "subject": ["Immunology", "Cell Biology", "Biochemistry", "Hematology"]}, {"indexed": {"date-parts": [[2019, 12, 4]], "date-time": "2019-12-04T01:29:09Z", "timestamp": 1575422949269}, "reference-count": 0, "publisher": "The Endocrine Society", "issue": "12", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Molecular Endocrinology"], "published-print": {"date-parts": [[1995, 12]]}, "DOI": "10.1210/mend.9.12.8614415", "type": "journal-article", "created": {"date-parts": [[2014, 1, 8]], "date-time": "2014-01-08T17:28:55Z", "timestamp": 1389202135000}, "page": "1791-1803", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Effect of PML and PML-RAR on the transactivation properties and subcellular distribution of steroid hormone receptors."], "prefix": "10.1210", "volume": "9", "author": [{"given": "A", "family": "Guiochon-Mantel", "sequence": "first", "affiliation": []}, {"given": "J F", "family": "Savouret", "sequence": "additional", "affiliation": []}, {"given": "F", "family": "Quignon", "sequence": "additional", "affiliation": []}, {"given": "K", "family": "Delabre", "sequence": "additional", "affiliation": []}, {"given": "E", "family": "Milgrom", "sequence": "additional", "affiliation": []}, {"given": "H", "family": "De The", "sequence": "additional", "affiliation": []}], "member": "80", "container-title": ["Molecular Endocrinology"], "language": "en", "link": [{"URL": "http://academic.oup.com/mend/article-pdf/9/12/1791/9080811/mend1791.pdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 8, 25]], "date-time": "2017-08-25T04:05:48Z", "timestamp": 1503633948000}, "score": 32.354866, "issued": {"date-parts": [[1995, 12]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1995, 12]]}, "issue": "12"}, "alternative-id": ["10.1210/mend.9.12.8614415"], "URL": "http://dx.doi.org/10.1210/mend.9.12.8614415", "ISSN": ["0888-8809", "1944-9917"], "issn-type": [{"value": "0888-8809", "type": "print"}, {"value": "1944-9917", "type": "electronic"}], "subject": ["Molecular Biology", "Endocrinology", "General Medicine"]}, {"indexed": {"date-parts": [[2019, 12, 2]], "date-time": "2019-12-02T19:33:49Z", "timestamp": 1575315229311}, "reference-count": 104, "publisher": "Springer Science and Business Media LLC", "issue": "48", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2008, 10, 1]], "date-time": "2008-10-01T00:00:00Z", "timestamp": 1222819200000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Oncogene"], "published-print": {"date-parts": [[2008, 10]]}, "DOI": "10.1038/onc.2008.305", "type": "journal-article", "created": {"date-parts": [[2008, 10, 20]], "date-time": "2008-10-20T07:03:30Z", "timestamp": 1224486210000}, "page": "6299-6312", "source": "Crossref", "is-referenced-by-count": 93, "title": ["Regulation of apoptosis by PML and the PML-NBs"], "prefix": "10.1038", "volume": "27", "author": [{"given": "R", "family": "Bernardi", "sequence": "first", "affiliation": []}, {"given": "A", "family": "Papa", "sequence": "additional", "affiliation": []}, {"given": "P P", "family": "Pandolfi", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2008, 10, 20]]}, "reference": [{"key": "BFonc2008305_CR1", "doi-asserted-by": "crossref", "first-page": "3653", "DOI": "10.1038/sj.onc.1211036", "volume": "27", "author": "O Alsheich-Bartok", "year": "2008", "unstructured": "Alsheich-Bartok O, Haupt S, Alkalay-Snir I, Saito S, Appella E, Haupt Y . (2008). PML enhances the regulation of p53 by CK1 in response to DNA damage. Oncogene 27: 3653\u20133661.", "journal-title": "Oncogene"}, {"key": "BFonc2008305_CR2", "doi-asserted-by": "crossref", "first-page": "2688", "DOI": "10.4161/cc.5.22.3504", "volume": "5", "author": "C Bellodi", "year": "2006", "unstructured": "Bellodi C, Kindle K, Bernassola F, Cossarizza A, Dinsdale D, Melino G et al. (2006). A cytoplasmic PML mutant inhibits p53 function. Cell Cycle 5: 2688\u20132692.", "journal-title": "Cell Cycle"}, {"key": "BFonc2008305_CR3", "doi-asserted-by": "crossref", "first-page": "9048", "DOI": "10.1038/sj.onc.1207106", "volume": "22", "author": "R Bernardi", "year": "2003", "unstructured": "Bernardi R, Pandolfi PP . (2003). Role of PML and the PML-nuclear body in the control of programmed cell death. Oncogene 22: 9048\u20139057.", "journal-title": "Oncogene"}, {"key": "BFonc2008305_CR4", "doi-asserted-by": "crossref", "first-page": "1006", "DOI": "10.1038/nrm2277", "volume": "8", "author": "R Bernardi", "year": "2007", "unstructured": "Bernardi R, Pandolfi PP . (2007). Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies. Nat Rev Mol Cell Biol 8: 1006\u20131016.", "journal-title": "Nat Rev Mol Cell Biol"}, {"key": "BFonc2008305_CR5", "doi-asserted-by": "crossref", "first-page": "665", "DOI": "10.1038/ncb1147", "volume": "6", "author": "R Bernardi", "year": "2004", "unstructured": "Bernardi R, Scaglioni PP, Bergmann S, Horn HF, Vousden KH, Pandolfi PP . (2004). PML regulates p53 stability by sequestering Mdm2 to the nucleolus. Nat Cell Biol 6: 665\u2013672.", "journal-title": "Nat Cell Biol"}, {"key": "BFonc2008305_CR6", "doi-asserted-by": "crossref", "first-page": "843", "DOI": "10.1016/S1097-2765(02)00699-8", "volume": "10", "author": "JL Best", "year": "2002", "unstructured": "Best JL, Ganiatsas S, Agarwal S, Changou A, Salomoni P, Shirihai O et al. (2002). SUMO-1 protease-1 regulates gene transcription through PML. Mol Cell 10: 843\u2013855.", "journal-title": "Mol Cell"}, {"key": "BFonc2008305_CR7", "doi-asserted-by": "crossref", "first-page": "3358", "DOI": "10.1093/emboj/cdf341", "volume": "21", "author": "O Bischof", "year": "2002", "unstructured": "Bischof O, Kirsh O, Pearson M, Itahana K, Pelicci PG, Dejean A . (2002). Deconstructing PML-induced premature senescence. EMBO J 21: 3358\u20133369.", "journal-title": "EMBO J"}, {"key": "BFonc2008305_CR8", "doi-asserted-by": "crossref", "first-page": "3461", "DOI": "10.1038/sj.onc.1201899", "volume": "16", "author": "N Bissonnette", "year": "1998", "unstructured": "Bissonnette N, Hunting DJ . (1998). p21-induced cycle arrest in G1 protects cells from apoptosis induced by UV-irradiation or RNA polymerase II blockage. Oncogene 16: 3461\u20133469.", "journal-title": "Oncogene"}, {"key": "BFonc2008305_CR9", "doi-asserted-by": "crossref", "first-page": "283", "DOI": "10.1083/jcb.148.2.283", "volume": "148", "author": "FM Boisvert", "year": "2000", "unstructured": "Boisvert FM, Hendzel MJ, Bazett-Jones DP . (2000). Promyelocytic leukemia (PML) nuclear bodies are protein structures that do not accumulate RNA. J Cell Biol 148: 283\u2013292.", "journal-title": "J Cell Biol"}, {"key": "BFonc2008305_CR10", "doi-asserted-by": "crossref", "first-page": "5259", "DOI": "10.1128/MCB.22.15.5259-5269.2002", "volume": "22", "author": "KL Borden", "year": "2002", "unstructured": "Borden KL . (2002). Pondering the promyelocytic leukemia protein (PML) puzzle: possible functions for PML nuclear bodies. Mol Cell Biol 22: 5259\u20135269.", "journal-title": "Mol Cell Biol"}, {"key": "BFonc2008305_CR11", "doi-asserted-by": "crossref", "first-page": "3415", "DOI": "10.1038/sj.onc.1210128", "volume": "26", "author": "M Buschbeck", "year": "2006", "unstructured": "Buschbeck M, Uribesalgo I, Ledl A, Gutierrez A, Minucci S, Muller S et al. (2006). PML4 induces differentiation by Myc destabilization. Oncogene 26: 3415\u20133422.", "journal-title": "Oncogene"}, {"key": "BFonc2008305_CR12", "doi-asserted-by": "crossref", "first-page": "923", "DOI": "10.1158/1535-7163.MCT-07-0540", "volume": "7", "author": "X Cao", "year": "2008", "unstructured": "Cao X, Clavijo C, Li X, Lin HH, Chen Y, Shih HM et al. (2008). SUMOylation of HMGA2: selective destabilization of promyelocytic leukemia protein via proteasome. Mol Cancer Ther 7: 923\u2013934.", "journal-title": "Mol Cancer Ther"}, {"key": "BFonc2008305_CR13", "doi-asserted-by": "crossref", "first-page": "1633", "DOI": "10.1038/sj.onc.1205227", "volume": "21", "author": "R Carbone", "year": "2002", "unstructured": "Carbone R, Pearson M, Minucci S, Pelicci PG . (2002). PML NBs associate with the hMre11 complex and p53 at sites of irradiation induced DNA damage. Oncogene 21: 1633\u20131640.", "journal-title": "Oncogene"}, {"key": "BFonc2008305_CR14", "doi-asserted-by": "crossref", "first-page": "326", "DOI": "10.1007/BF02940312", "volume": "13", "author": "HJ Chang", "year": "2007", "unstructured": "Chang HJ, Yoo BC, Kim SW, Lee BL, Kim WH . (2007). Significance of PML and p53 protein as molecular prognostic markers of gallbladder carcinomas. Pathol Oncol Res 13: 326\u2013335.", "journal-title": "Pathol Oncol Res"}, {"key": "BFonc2008305_CR15", "doi-asserted-by": "crossref", "first-page": "1860", "DOI": "10.1126/science.281.5384.1860", "volume": "281", "author": "HY Chang", "year": "1998", "unstructured": "Chang HY, Nishitoh H, Yang X, Ichijo H, Baltimore D . (1998). Activation of apoptosis signal-regulating kinase 1 (ASK1) by the adapter protein Daxx. Science 281: 1860\u20131863.", "journal-title": "Science"}, {"key": "BFonc2008305_CR16", "first-page": "3646", "volume": "85", "author": "KS Chang", "year": "1995", "unstructured": "Chang KS, Fan YH, Andreeff M, Liu J, Mu ZM . (1995). The PML gene encodes a phosphoprotein associated with the nuclear matrix. Blood 85: 3646\u20133653.", "journal-title": "Blood"}, {"key": "BFonc2008305_CR17", "first-page": "717", "volume": "1", "author": "Y Cho", "year": "1998", "unstructured": "Cho Y, Lee I, Maul GG, Yu E . (1998). A novel nuclear substructure, ND10: distribution in normal and neoplastic human tissues. Int J Mol Med 1: 717\u2013724.", "journal-title": "Int J Mol Med"}, {"key": "BFonc2008305_CR18", "doi-asserted-by": "crossref", "first-page": "6192", "DOI": "10.1158/0008-5472.CAN-05-3792", "volume": "66", "author": "W Condemine", "year": "2006", "unstructured": "Condemine W, Takahashi Y, Zhu J, Puvion-Dutilleul F, Guegan S, Janin A et al. (2006). Characterization of endogenous human promyelocytic leukemia isoforms. Cancer Res 66: 6192\u20136198.", "journal-title": "Cancer Res"}, {"key": "BFonc2008305_CR19", "doi-asserted-by": "crossref", "first-page": "9026", "DOI": "10.1158/0008-5472.CAN-06-1047", "volume": "66", "author": "R Croxton", "year": "2006", "unstructured": "Croxton R, Puto LA, de Belle I, Thomas M, Torii S, Hanaii F et al. (2006). Daxx represses expression of a subset of antiapoptotic genes regulated by nuclear factor-kappaB. Cancer Res 66: 9026\u20139035.", "journal-title": "Cancer Res"}, {"key": "BFonc2008305_CR20", "doi-asserted-by": "crossref", "first-page": "11", "DOI": "10.1038/ncb714", "volume": "4", "author": "G D\u2019Orazi", "year": "2002", "unstructured": "D\u2019Orazi G, Cecchinelli B, Bruno T, Manni I, Higashimoto Y, Saito S et al. (2002). Homeodomain-interacting protein kinase-2 phosphorylates p53 at Ser 46 and mediates apoptosis. Nat Cell Biol 4: 11\u201319.", "journal-title": "Nat Cell Biol"}, {"key": "BFonc2008305_CR21", "first-page": "1858", "volume": "82", "author": "MT Daniel", "year": "1993", "unstructured": "Daniel MT, Koken M, Romagne O, Barbey S, Bazarbachi A, Stadler M et al. (1993). PML protein expression in hematopoietic and acute promyelocytic leukemia cells. Blood 82: 1858\u20131867.", "journal-title": "Blood"}, {"key": "BFonc2008305_CR22", "doi-asserted-by": "crossref", "first-page": "523", "DOI": "10.1016/S1097-2765(04)00062-0", "volume": "13", "author": "E de Stanchina", "year": "2004", "unstructured": "de Stanchina E, Querido E, Narita M, Davuluri RV, Pandolfi PP, Ferbeyre G et al. (2004). PML is a direct p53 target that modulates p53 effector functions. Mol Cell 13: 523\u2013535.", "journal-title": "Mol Cell"}, {"key": "BFonc2008305_CR23", "doi-asserted-by": "crossref", "first-page": "675", "DOI": "10.1016/0092-8674(91)90113-D", "volume": "66", "author": "H de The", "year": "1991", "unstructured": "de The H, Lavau C, Marchio A, Chomienne C, Degos L, Dejean A . (1991). The PML-RAR alpha fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR. Cell 66: 675\u2013684.", "journal-title": "Cell"}, {"key": "BFonc2008305_CR24", "doi-asserted-by": "crossref", "first-page": "963", "DOI": "10.1002/bies.20089", "volume": "26", "author": "G Dellaire", "year": "2004", "unstructured": "Dellaire G, Bazett-Jones DP . (2004). PML nuclear bodies: dynamic sensors of DNA damage and cellular stress. Bioessays 26: 963\u2013977.", "journal-title": "Bioessays"}, {"key": "BFonc2008305_CR25", "doi-asserted-by": "crossref", "first-page": "55", "DOI": "10.1083/jcb.200604009", "volume": "175", "author": "G Dellaire", "year": "2006", "unstructured": "Dellaire G, Ching RW, Ahmed K, Jalali F, Tse KC, Bristow RG et al. (2006). Promyelocytic leukemia nuclear bodies behave as DNA damage sensors whose response to DNA double-strand breaks is regulated by NBS1 and the kinases ATM, Chk2, and ATR. J Cell Biol 175: 55\u201366.", "journal-title": "J Cell Biol"}, {"key": "BFonc2008305_CR26", "doi-asserted-by": "crossref", "first-page": "11156", "DOI": "10.1074/jbc.M111763200", "volume": "277", "author": "AV Emelyanov", "year": "2002", "unstructured": "Emelyanov AV, Kovac CR, Sepulveda MA, Birshtein BK . (2002). The interaction of Pax5 (BSAP) with Daxx can result in transcriptional activation in B cells. J Biol Chem 277: 11156\u201311164.", "journal-title": "J Biol Chem"}, {"key": "BFonc2008305_CR27", "doi-asserted-by": "crossref", "first-page": "1519", "DOI": "10.1093/emboj/16.7.1519", "volume": "16", "author": "RD Everett", "year": "1997", "unstructured": "Everett RD, Meredith M, Orr A, Cross A, Kathoria M, Parkinson J . (1997). A novel ubiquitin-specific protease is dynamically associated with the PML nuclear domain and binds to a herpesvirus regulatory protein. EMBO J 16: 1519\u20131530.", "journal-title": "EMBO J"}, {"key": "BFonc2008305_CR28", "first-page": "2015", "volume": "14", "author": "G Ferbeyre", "year": "2000", "unstructured": "Ferbeyre G, de Stanchina E, Querido E, Baptiste N, Prives C, Lowe SW . (2000). PML is induced by oncogenic ras and promotes premature senescence. Genes Dev 14: 2015\u20132027.", "journal-title": "Genes Dev"}, {"key": "BFonc2008305_CR29", "doi-asserted-by": "crossref", "first-page": "6185", "DOI": "10.1093/emboj/19.22.6185", "volume": "19", "author": "V Fogal", "year": "2000", "unstructured": "Fogal V, Gostissa M, Sandy P, Zacchi P, Sternsdorf T, Jensen K et al. (2000). Regulation of p53 activity in nuclear bodies by a specific PML isoform. EMBO J 19: 6185\u20136195.", "journal-title": "EMBO J"}, {"key": "BFonc2008305_CR30", "doi-asserted-by": "crossref", "first-page": "5401", "DOI": "10.1038/sj.onc.1208714", "volume": "24", "author": "C Fu", "year": "2005", "unstructured": "Fu C, Ahmed K, Ding H, Ding X, Lan J, Yang Z et al. (2005). Stabilization of PML nuclear localization by conjugation and oligomerization of SUMO-3. Oncogene 24: 5401\u20135413.", "journal-title": "Oncogene"}, {"key": "BFonc2008305_CR31", "doi-asserted-by": "crossref", "first-page": "730", "DOI": "10.1038/35036365", "volume": "2", "author": "A Guo", "year": "2000", "unstructured": "Guo A, Salomoni P, Luo J, Shih A, Zhong S, Gu W et al. (2000). The function of PML in p53-dependent apoptosis. Nat Cell Biol 2: 730\u2013736.", "journal-title": "Nat Cell Biol"}, {"key": "BFonc2008305_CR32", "doi-asserted-by": "crossref", "first-page": "13430", "DOI": "10.1074/jbc.M108029200", "volume": "277", "author": "Y Guo", "year": "2002", "unstructured": "Guo Y, Srinivasula SM, Druilhe A, Fernandes-Alnemri T, Alnemri ES . (2002). Caspase-2 induces apoptosis by releasing proapoptotic proteins from mitochondria. J Biol Chem 277: 13430\u201313437.", "journal-title": "J Biol Chem"}, {"key": "BFonc2008305_CR33", "doi-asserted-by": "crossref", "first-page": "269", "DOI": "10.1093/jnci/djh043", "volume": "96", "author": "C Gurrieri", "year": "2004", "unstructured": "Gurrieri C, Capodieci P, Bernardi R, Scaglioni PP, Nafa K, Rush LJ et al. (2004a). Loss of the tumor suppressor PML in human cancers of multiple histologic origins. J Natl Cancer Inst 96: 269\u2013279.", "journal-title": "J Natl Cancer Inst"}, {"key": "BFonc2008305_CR34", "doi-asserted-by": "crossref", "first-page": "2358", "DOI": "10.1182/blood-2003-07-2200", "volume": "103", "author": "C Gurrieri", "year": "2004", "unstructured": "Gurrieri C, Nafa K, Merghoub T, Bernardi R, Capodieci P, Biondi A et al. (2004b). Mutations of the PML tumor suppressor gene in acute promyelocytic leukemia. Blood 103: 2358\u20132362.", "journal-title": "Blood"}, {"key": "BFonc2008305_CR35", "doi-asserted-by": "crossref", "first-page": "1352", "DOI": "10.1126/science.1140735", "volume": "319", "author": "TD Halazonetis", "year": "2008", "unstructured": "Halazonetis TD, Gorgoulis VG, Bartek J . (2008). An oncogene-induced DNA damage model for cancer development. Science 319: 1352\u20131355.", "journal-title": "Science"}, {"key": "BFonc2008305_CR36", "doi-asserted-by": "crossref", "first-page": "389", "DOI": "10.1016/S1535-6108(04)00082-0", "volume": "5", "author": "F Hayakawa", "year": "2004", "unstructured": "Hayakawa F, Privalsky ML . (2004). Phosphorylation of PML by mitogen-activated protein kinases plays a key role in arsenic trioxide-mediated apoptosis. Cancer Cell 5: 389\u2013401.", "journal-title": "Cancer Cell"}, {"key": "BFonc2008305_CR37", "doi-asserted-by": "crossref", "first-page": "5", "DOI": "10.1016/j.neulet.2005.11.057", "volume": "397", "author": "N Hayashi", "year": "2006", "unstructured": "Hayashi N, Shirakura H, Uehara T, Nomura Y . (2006). Relationship between SUMO-1 modification of caspase-7 and its nuclear localization in human neuronal cells. Neurosci Lett 397: 5\u20139.", "journal-title": "Neurosci Lett"}, {"key": "BFonc2008305_CR38", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1038/ncb715", "volume": "4", "author": "TG Hofmann", "year": "2002", "unstructured": "Hofmann TG, Moller A, Sirma H, Zentgraf H, Taya Y, Droge W et al. (2002). Regulation of p53 activity by its interaction with homeodomain-interacting protein kinase-2. Nat Cell Biol 4: 1\u201310.", "journal-title": "Nat Cell Biol"}, {"key": "BFonc2008305_CR39", "doi-asserted-by": "crossref", "first-page": "1290", "DOI": "10.1038/sj.cdd.4401313", "volume": "10", "author": "TG Hofmann", "year": "2003", "unstructured": "Hofmann TG, Will H . (2003). Body language: the function of PML nuclear bodies in apoptosis regulation. Cell Death Differ 10: 1290\u20131299.", "journal-title": "Cell Death Differ"}, {"key": "BFonc2008305_CR40", "doi-asserted-by": "crossref", "first-page": "777", "DOI": "10.1038/19709", "volume": "398", "author": "Y Imai", "year": "1999", "unstructured": "Imai Y, Kimura T, Murakami A, Yajima N, Sakamaki K, Yonehara S . (1999). The CED-4-homologous protein FLASH is involved in Fas-mediated activation of caspase-8 during apoptosis. Nature 398: 777\u2013785.", "journal-title": "Nature"}, {"key": "BFonc2008305_CR41", "doi-asserted-by": "crossref", "first-page": "221", "DOI": "10.1083/jcb.147.2.221", "volume": "147", "author": "AM Ishov", "year": "1999", "unstructured": "Ishov AM, Sotnikov AG, Negorev D, Vladimirova OV, Neff N, Kamitani T et al. (1999). PML is critical for ND10 formation and recruits the PML-interacting protein daxx to this nuclear structure when modified by SUMO-1. J Cell Biol 147: 221\u2013234.", "journal-title": "J Cell Biol"}, {"key": "BFonc2008305_CR42", "doi-asserted-by": "crossref", "first-page": "1072", "DOI": "10.1038/nature07016", "volume": "453", "author": "K Ito", "year": "2008", "unstructured": "Ito K, Bernardi R, Morotti A, Matsuoka S, Saglio G, Ikeda Y et al. (2008). PML targeting eradicates quiescent leukaemia-initiating cells. Nature 453: 1072\u20131078.", "journal-title": "Nature"}, {"key": "BFonc2008305_CR43", "doi-asserted-by": "crossref", "first-page": "7223", "DOI": "10.1038/sj.onc.1204765", "volume": "20", "author": "K Jensen", "year": "2001", "unstructured": "Jensen K, Shiels C, Freemont PS . (2001). PML protein isoforms and the RBCC/TRIM motif. Oncogene 20: 7223\u20137233.", "journal-title": "Oncogene"}, {"key": "BFonc2008305_CR44", "doi-asserted-by": "crossref", "first-page": "663", "DOI": "10.1016/0092-8674(91)90112-C", "volume": "66", "author": "A Kakizuka", "year": "1991", "unstructured": "Kakizuka A, Miller Jr WH, Umesono K, Warrell Jr RP, Frankel SR, Murty VV et al. (1991). Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RAR alpha with a novel putative transcription factor, PML. Cell 66: 663\u2013674.", "journal-title": "Cell"}, {"key": "BFonc2008305_CR45", "doi-asserted-by": "crossref", "first-page": "611", "DOI": "10.1016/S1074-7613(00)80212-5", "volume": "12", "author": "FC Kischkel", "year": "2000", "unstructured": "Kischkel FC, Lawrence DA, Chuntharapai A, Schow P, Kim KJ, Ashkenazi A . (2000). Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5. Immunity 12: 611\u2013620.", "journal-title": "Immunity"}, {"key": "BFonc2008305_CR46", "doi-asserted-by": "crossref", "first-page": "2753", "DOI": "10.1016/j.yexcr.2007.03.032", "volume": "313", "author": "N Komura", "year": "2007", "unstructured": "Komura N, Asakawa M, Umezawa K, Segawa K . (2007). Tyrosine kinase inhibitor, methyl 2,5-dihydromethylcinnimate, induces PML nuclear body formation and apoptosis in tumor cells. Exp Cell Res 313: 2753\u20132765.", "journal-title": "Exp Cell Res"}, {"key": "BFonc2008305_CR47", "doi-asserted-by": "crossref", "first-page": "771", "DOI": "10.4161/cc.6.7.4046", "volume": "6", "author": "E Krieghoff", "year": "2007", "unstructured": "Krieghoff E, Milovic-Holm K, Hofmann TG . (2007). FLASH meets nuclear bodies: CD95 receptor signals via a nuclear pathway. Cell Cycle 6: 771\u2013775.", "journal-title": "Cell Cycle"}, {"key": "BFonc2008305_CR48", "doi-asserted-by": "crossref", "first-page": "3917", "DOI": "10.1242/jcs.00714", "volume": "116", "author": "S Kurki", "year": "2003", "unstructured": "Kurki S, Latonen L, Laiho M . (2003). Cellular stress and DNA damage invoke temporally distinct Mdm2, p53 and PML complexes and damage-specific nuclear relocalization. J Cell Sci 116: 3917\u20133925.", "journal-title": "J Cell Sci"}, {"key": "BFonc2008305_CR49", "doi-asserted-by": "crossref", "first-page": "113", "DOI": "10.1016/S0027-5107(00)00133-0", "volume": "457", "author": "D Lackinger", "year": "2000", "unstructured": "Lackinger D, Kaina B . (2000). Primary mouse fibroblasts deficient for c-Fos, p53 or for both proteins are hypersensitive to UV light and alkylating agent-induced chromosomal breakage and apoptosis. Mutat Res 457: 113\u2013123.", "journal-title": "Mutat Res"}, {"key": "BFonc2008305_CR50", "doi-asserted-by": "crossref", "first-page": "547", "DOI": "10.1038/ncb1717", "volume": "10", "author": "V Lallemand-Breitenbach", "year": "2008", "unstructured": "Lallemand-Breitenbach V, Jeanne M, Benhenda S, Nasr R, Lei M, Peres L et al. (2008). Arsenic degrades PML or PML-RARalpha through a SUMO-triggered RNF4/ubiquitin-mediated pathway. Nat Cell Biol 10: 547\u2013555.", "journal-title": "Nat Cell Biol"}, {"key": "BFonc2008305_CR51", "doi-asserted-by": "crossref", "first-page": "1352", "DOI": "10.1126/science.1074721", "volume": "297", "author": "P Lassus", "year": "2002", "unstructured": "Lassus P, Opitz-Araya X, Lazebnik Y . (2002). Requirement for caspase-2 in stress-induced apoptosis before mitochondrial permeabilization. Science 297: 1352\u20131354.", "journal-title": "Science"}, {"key": "BFonc2008305_CR52", "doi-asserted-by": "crossref", "first-page": "1839", "DOI": "10.1038/sj.onc.1201705", "volume": "16", "author": "XF Le", "year": "1998", "unstructured": "Le XF, Vallian S, Mu ZM, Hung MC, Chang KS . (1998). Recombinant PML adenovirus suppresses growth and tumorigenicity of human breast cancer cells by inducing G1 cell cycle arrest and apoptosis. Oncogene 16: 1839\u20131849.", "journal-title": "Oncogene"}, {"key": "BFonc2008305_CR53", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1038/sj.onc.1204063", "volume": "20", "author": "F Lehembre", "year": "2001", "unstructured": "Lehembre F, Muller S, Pandolfi PP, Dejean A . (2001). Regulation of Pax3 transcriptional activity by SUMO-1-modified PML. Oncogene 20: 1\u20139.", "journal-title": "Oncogene"}, {"key": "BFonc2008305_CR54", "doi-asserted-by": "crossref", "first-page": "1784", "DOI": "10.1128/MCB.20.5.1784-1796.2000", "volume": "20", "author": "H Li", "year": "2000", "unstructured": "Li H, Leo C, Zhu J, Wu X, O\u2019Neil J, Park EJ et al. (2000). Sequestration and inhibition of Daxx-mediated transcriptional repression by PML. Mol Cell Biol 20: 1784\u20131796.", "journal-title": "Mol Cell Biol"}, {"key": "BFonc2008305_CR55", "doi-asserted-by": "crossref", "first-page": "648", "DOI": "10.1038/nature737", "volume": "416", "author": "M Li", "year": "2002", "unstructured": "Li M, Chen D, Shiloh A, Luo J, Nikolaev AY, Qin J et al. (2002). Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization. Nature 416: 648\u2013653.", "journal-title": "Nature"}, {"key": "BFonc2008305_CR56", "doi-asserted-by": "crossref", "first-page": "205", "DOI": "10.1038/nature02783", "volume": "431", "author": "HK Lin", "year": "2004", "unstructured": "Lin HK, Bergmann S, Pandolfi PP . (2004). Cytoplasmic PML function in TGF-beta signalling. Nature 431: 205\u2013211.", "journal-title": "Nature"}, {"key": "BFonc2008305_CR57", "doi-asserted-by": "crossref", "first-page": "1965", "DOI": "10.1084/jem.181.6.1965", "volume": "181", "author": "JH Liu", "year": "1995", "unstructured": "Liu JH, Mu ZM, Chang KS . (1995). PML suppresses oncogenic transformation of NIH/3T3 cells by activated neu. J Exp Med 181: 1965\u20131973.", "journal-title": "J Exp Med"}, {"key": "BFonc2008305_CR58", "doi-asserted-by": "crossref", "first-page": "33134", "DOI": "10.1074/jbc.M301264200", "volume": "278", "author": "I Louria-Hayon", "year": "2003", "unstructured": "Louria-Hayon I, Grossman T, Sionov RV, Alsheich O, Pandolfi PP, Haupt Y . (2003). The promyelocytic leukemia protein protects p53 from Mdm2-mediated inhibition and degradation. J Biol Chem 278: 33134\u201333141.", "journal-title": "J Biol Chem"}, {"key": "BFonc2008305_CR59", "doi-asserted-by": "crossref", "first-page": "e2277", "DOI": "10.1371/journal.pone.0002277", "volume": "3", "author": "BA McNally", "year": "2008", "unstructured": "McNally BA, Trgovcich J, Maul GG, Liu Y, Zheng P . (2008). A role for cytoplasmic PML in cellular resistance to viral infection. PLoS ONE 3: e2277.", "journal-title": "PLoS ONE"}, {"key": "BFonc2008305_CR60", "doi-asserted-by": "crossref", "first-page": "5073", "DOI": "10.1073/pnas.0608773104", "volume": "104", "author": "I Meinecke", "year": "2007", "unstructured": "Meinecke I, Cinski A, Baier A, Peters MA, Dankbar B, Wille A et al. (2007). Modification of nuclear PML protein by SUMO-1 regulates Fas-induced apoptosis in rheumatoid arthritis synovial fibroblasts. Proc Natl Acad Sci USA 104: 5073\u20135078.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "BFonc2008305_CR61", "first-page": "3167", "volume": "93", "author": "A Melnick", "year": "1999", "unstructured": "Melnick A, Licht JD . (1999). Deconstructing a disease: RARalpha, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia. Blood 93: 3167\u20133215.", "journal-title": "Blood"}, {"key": "BFonc2008305_CR62", "doi-asserted-by": "crossref", "first-page": "1918", "DOI": "10.1101/gad.13.15.1918", "volume": "13", "author": "JS Michaelson", "year": "1999", "unstructured": "Michaelson JS, Bader D, Kuo F, Kozak C, Leder P . (1999). Loss of Daxx, a promiscuously interacting protein, results in extensive apoptosis in early mouse development. Genes Dev 13: 1918\u20131923.", "journal-title": "Genes Dev"}, {"key": "BFonc2008305_CR63", "doi-asserted-by": "crossref", "first-page": "345", "DOI": "10.1242/jcs.00234", "volume": "116", "author": "JS Michaelson", "year": "2003", "unstructured": "Michaelson JS, Leder P . (2003). RNAi reveals anti-apoptotic and transcriptionally repressive activities of DAXX. J Cell Sci 116: 345\u2013352.", "journal-title": "J Cell Sci"}, {"key": "BFonc2008305_CR64", "doi-asserted-by": "crossref", "first-page": "391", "DOI": "10.1038/sj.emboj.7601504", "volume": "26", "author": "K Milovic-Holm", "year": "2007", "unstructured": "Milovic-Holm K, Krieghoff E, Jensen K, Will H, Hofmann TG . (2007). FLASH links the CD95 signaling pathway to the cell nucleus and nuclear bodies. EMBO J 26: 391\u2013401.", "journal-title": "EMBO J"}, {"key": "BFonc2008305_CR65", "first-page": "4310", "volume": "63", "author": "A Moller", "year": "2003", "unstructured": "Moller A, Sirma H, Hofmann TG, Rueffer S, Klimczak E, Droge W et al. (2003). PML is required for homeodomain-interacting protein kinase 2 (HIPK2)-mediated p53 phosphorylation and cell cycle arrest but is dispensable for the formation of HIPK domains. Cancer Res 63: 4310\u20134314.", "journal-title": "Cancer Res"}, {"key": "BFonc2008305_CR66", "doi-asserted-by": "crossref", "first-page": "975", "DOI": "10.1083/jcb.200204039", "volume": "157", "author": "M Morgan", "year": "2002", "unstructured": "Morgan M, Thorburn J, Pandolfi PP, Thorburn A . (2002). Nuclear and cytoplasmic shuttling of TRADD induces apoptosis via different mechanisms. J Cell Biol 157: 975\u2013984.", "journal-title": "J Cell Biol"}, {"key": "BFonc2008305_CR67", "doi-asserted-by": "crossref", "first-page": "2063", "DOI": "10.1093/carcin/18.11.2063", "volume": "18", "author": "ZM Mu", "year": "1997", "unstructured": "Mu ZM, Le XF, Vallian S, Glassman AB, Chang KS . (1997). Stable overexpression of PML alters regulation of cell cycle progression in HeLa cells. Carcinogenesis 18: 2063\u20132069.", "journal-title": "Carcinogenesis"}, {"key": "BFonc2008305_CR68", "doi-asserted-by": "crossref", "first-page": "939", "DOI": "10.1083/jcb.200510103", "volume": "174", "author": "D Mukhopadhyay", "year": "2006", "unstructured": "Mukhopadhyay D, Ayaydin F, Kolli N, Tan SH, Anan T, Kametaka A et al. (2006). SUSP1 antagonizes formation of highly SUMO2/3-conjugated species. J Cell Biol 174: 939\u2013949.", "journal-title": "J Cell Biol"}, {"key": "BFonc2008305_CR69", "doi-asserted-by": "crossref", "first-page": "292", "DOI": "10.1182/blood-2004-03-1185", "volume": "105", "author": "LA Nguyen", "year": "2005", "unstructured": "Nguyen LA, Pandolfi PP, Aikawa Y, Tagata Y, Ohki M, Kitabayashi I . (2005). Physical and functional link of the leukemia-associated factors AML1 and PML. Blood 105: 292\u2013300.", "journal-title": "Blood"}, {"key": "BFonc2008305_CR70", "first-page": "1285", "volume": "6", "author": "PP Pandolfi", "year": "1991", "unstructured": "Pandolfi PP, Grignani F, Alcalay M, Mencarelli A, Biondi A, LoCoco F et al. (1991). Structure and origin of the acute promyelocytic leukemia myl/RAR alpha cDNA and characterization of its retinoid-binding and transactivation properties. Oncogene 6: 1285\u20131292.", "journal-title": "Oncogene"}, {"key": "BFonc2008305_CR71", "doi-asserted-by": "crossref", "first-page": "15147", "DOI": "10.1074/jbc.M112338200", "volume": "277", "author": "G Paroni", "year": "2002", "unstructured": "Paroni G, Henderson C, Schneider C, Brancolini C . (2002). Caspase-2 can trigger cytochrome C release and apoptosis from the nucleus. J Biol Chem 277: 15147\u201315161.", "journal-title": "J Biol Chem"}, {"key": "BFonc2008305_CR72", "doi-asserted-by": "crossref", "first-page": "207", "DOI": "10.1038/35018127", "volume": "406", "author": "M Pearson", "year": "2000", "unstructured": "Pearson M, Carbone R, Sebastiani C, Cioce M, Fagioli M, Saito S et al. (2000). PML regulates p53 acetylation and premature senescence induced by oncogenic Ras. Nature 406: 207\u2013210.", "journal-title": "Nature"}, {"key": "BFonc2008305_CR73", "doi-asserted-by": "crossref", "first-page": "507", "DOI": "10.1038/ncb0508-507", "volume": "10", "author": "K Petrie", "year": "2008", "unstructured": "Petrie K, Zelent A . (2008). Marked for death. Nat Cell Biol 10: 507\u2013509.", "journal-title": "Nat Cell Biol"}, {"key": "BFonc2008305_CR74", "doi-asserted-by": "crossref", "first-page": "7216", "DOI": "10.1038/sj.onc.1204855", "volume": "20", "author": "F Piazza", "year": "2001", "unstructured": "Piazza F, Gurrieri C, Pandolfi PP . (2001). The theory of APL. Oncogene 20: 7216\u20137222.", "journal-title": "Oncogene"}, {"key": "BFonc2008305_CR75", "doi-asserted-by": "crossref", "first-page": "259", "DOI": "10.1038/3068", "volume": "20", "author": "F Quignon", "year": "1998", "unstructured": "Quignon F, De Bels F, Koken M, Feunteun J, Ameisen JC, de The H . (1998). PML induces a novel caspase-independent death process. Nat Genet 20: 259\u2013265.", "journal-title": "Nat Genet"}, {"key": "BFonc2008305_CR76", "doi-asserted-by": "crossref", "first-page": "997", "DOI": "10.1128/MCB.01848-07", "volume": "28", "author": "EL Reineke", "year": "2008", "unstructured": "Reineke EL, Lam M, Liu Q, Liu Y, Stanya KJ, Chang KS et al. (2008). Degradation of the tumor suppressor PML by Pin1 contributes to the cancer phenotype of breast cancer MDA-MB-231 cells. Mol Cell Biol 28: 997\u20131006.", "journal-title": "Mol Cell Biol"}, {"key": "BFonc2008305_CR77", "doi-asserted-by": "crossref", "first-page": "3686", "DOI": "10.1182/blood-2004-09-3782", "volume": "105", "author": "P Salomoni", "year": "2005", "unstructured": "Salomoni P, Bernardi R, Bergmann S, Changou A, Tuttle S, Pandolfi PP . (2005). The promyelocytic leukemia protein PML regulates c-Jun function in response to DNA damage. Blood 105: 3686\u20133690.", "journal-title": "Blood"}, {"key": "BFonc2008305_CR78", "doi-asserted-by": "crossref", "first-page": "400", "DOI": "10.1016/j.tibs.2007.08.001", "volume": "32", "author": "L Sanchez-Pulido", "year": "2007", "unstructured": "Sanchez-Pulido L, Valencia A, Rojas AM . (2007). Are promyelocytic leukaemia protein nuclear bodies a scaffold for caspase-2 programmed cell death? Trends Biochem Sci 32: 400\u2013406.", "journal-title": "Trends Biochem Sci"}, {"key": "BFonc2008305_CR79", "doi-asserted-by": "crossref", "first-page": "269", "DOI": "10.1016/j.cell.2006.05.041", "volume": "126", "author": "PP Scaglioni", "year": "2006", "unstructured": "Scaglioni PP, Yung TM, Cai LF, Erdjument-Bromage H, Kaufman AJ, Singh B et al. (2006). A CK2-dependent mechanism for degradation of the PML tumor suppressor. Cell 126: 269\u2013283.", "journal-title": "Cell"}, {"key": "BFonc2008305_CR80", "doi-asserted-by": "crossref", "first-page": "690", "DOI": "10.1038/nrm1200", "volume": "4", "author": "JS Seeler", "year": "2003", "unstructured": "Seeler JS, Dejean A . (2003). Nuclear and unclear functions of SUMO. Nat Rev Mol Cell Biol 4: 690\u2013699.", "journal-title": "Nat Rev Mol Cell Biol"}, {"key": "BFonc2008305_CR81", "doi-asserted-by": "crossref", "first-page": "1620", "DOI": "10.1038/sj.onc.1206140", "volume": "22", "author": "H Seker", "year": "2003", "unstructured": "Seker H, Rubbi C, Linke SP, Bowman ED, Garfield S, Hansen L et al. (2003). UV-C-induced DNA damage leads to p53-dependent nuclear trafficking of PML. Oncogene 22: 1620\u20131628.", "journal-title": "Oncogene"}, {"key": "BFonc2008305_CR82", "doi-asserted-by": "crossref", "first-page": "331", "DOI": "10.1016/j.molcel.2006.09.013", "volume": "24", "author": "TH Shen", "year": "2006", "unstructured": "Shen TH, Lin HK, Scaglioni PP, Yung TM, Pandolfi PP . (2006). The mechanisms of PML-nuclear body formation. Mol Cell 24: 331\u2013339.", "journal-title": "Mol Cell"}, {"key": "BFonc2008305_CR83", "doi-asserted-by": "crossref", "first-page": "12255", "DOI": "10.1073/pnas.94.23.12255", "volume": "94", "author": "ML Smith", "year": "1997", "unstructured": "Smith ML, Fornace Jr AJ . (1997). p53-mediated protective responses to UV irradiation. Proc Natl Acad Sci USA 94: 12255\u201312257.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "BFonc2008305_CR84", "first-page": "2565", "volume": "11", "author": "M Stadler", "year": "1995", "unstructured": "Stadler M, Chelbi-Alix MK, Koken MH, Venturini L, Lee C, Saib A et al. (1995). Transcriptional induction of the PML growth suppressor gene by interferons is mediated through an ISRE and a GAS element. Oncogene 11: 2565\u20132573.", "journal-title": "Oncogene"}, {"key": "BFonc2008305_CR85", "doi-asserted-by": "crossref", "first-page": "273", "DOI": "10.1038/sj.leu.2405024", "volume": "22", "author": "Y Tagata", "year": "2008", "unstructured": "Tagata Y, Yoshida H, Nguyen LA, Kato H, Ichikawa H, Tashiro F et al. (2008). Phosphorylation of PML is essential for activation of C/EBP epsilon and PU.1 to accelerate granulocytic differentiation. Leukemia 22: 273\u2013280.", "journal-title": "Leukemia"}, {"key": "BFonc2008305_CR86", "doi-asserted-by": "crossref", "first-page": "2819", "DOI": "10.1038/sj.onc.1207533", "volume": "23", "author": "Y Takahashi", "year": "2004", "unstructured": "Takahashi Y, Lallemand-Breitenbach V, Zhu J, de The H . (2004). PML nuclear bodies and apoptosis. Oncogene 23: 2819\u20132824.", "journal-title": "Oncogene"}, {"key": "BFonc2008305_CR87", "doi-asserted-by": "crossref", "first-page": "18124", "DOI": "10.1074/jbc.M800512200", "volume": "283", "author": "JA Tan", "year": "2008", "unstructured": "Tan JA, Sun Y, Song J, Chen Y, Krontiris TG, Durrin LK . (2008). Sumo conjugation to the MAR-binding protein, special at-rich sequence binding protein-1, targets it to promyelocytic nuclear bodies where it undergoes caspase cleavage. J Biol Chem 283: 18124\u201318134.", "journal-title": "J Biol Chem"}, {"key": "BFonc2008305_CR88", "doi-asserted-by": "crossref", "first-page": "645", "DOI": "10.4161/cbt.4.6.1729", "volume": "4", "author": "J Tang", "year": "2005", "unstructured": "Tang J, Xie W, Yang X . (2005). Association of caspase-2 with the promyelocytic leukemia protein nuclear bodies. Cancer Biol Ther 4: 645\u2013649.", "journal-title": "Cancer Biol Ther"}, {"key": "BFonc2008305_CR89", "doi-asserted-by": "crossref", "first-page": "538", "DOI": "10.1038/ncb1716", "volume": "10", "author": "MH Tatham", "year": "2008", "unstructured": "Tatham MH, Geoffroy MC, Shen L, Plechanovova A, Hattersley N, Jaffray EG et al. (2008). RNF4 is a poly-SUMO-specific E3 ubiquitin ligase required for arsenic-induced PML degradation. Nat Cell Biol 10: 538\u2013546.", "journal-title": "Nat Cell Biol"}, {"key": "BFonc2008305_CR90", "doi-asserted-by": "crossref", "first-page": "6037", "DOI": "10.1093/emboj/18.21.6037", "volume": "18", "author": "S Torii", "year": "1999", "unstructured": "Torii S, Egan DA, Evans RA, Reed JC . (1999). Human Daxx regulates Fas-induced apoptosis from nuclear PML oncogenic domains (PODs). EMBO J 18: 6037\u20136049.", "journal-title": "EMBO J"}, {"key": "BFonc2008305_CR91", "doi-asserted-by": "crossref", "first-page": "870", "DOI": "10.1126/science.288.5467.870", "volume": "288", "author": "C Tournier", "year": "2000", "unstructured": "Tournier C, Hess P, Yang DD, Xu J, Turner TK, Nimnual A et al. (2000). Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway. Science 288: 870\u2013874.", "journal-title": "Science"}, {"key": "BFonc2008305_CR92", "doi-asserted-by": "crossref", "first-page": "523", "DOI": "10.1038/nature04809", "volume": "441", "author": "LC Trotman", "year": "2006", "unstructured": "Trotman LC, Alimonti A, Scaglioni PP, Koutcher JA, Cordon-Cardo C, Pandolfi PP . (2006). Identification of a tumour suppressor network opposing nuclear Akt function. Nature 441: 523\u2013527.", "journal-title": "Nature"}, {"key": "BFonc2008305_CR93", "doi-asserted-by": "crossref", "first-page": "713", "DOI": "10.1038/381713a0", "volume": "381", "author": "T Waldman", "year": "1996", "unstructured": "Waldman T, Lengauer C, Kinzler KW, Vogelstein B . (1996). Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21. Nature 381: 713\u2013716.", "journal-title": "Nature"}, {"key": "BFonc2008305_CR94", "doi-asserted-by": "crossref", "first-page": "266", "DOI": "10.1038/3073", "volume": "20", "author": "ZG Wang", "year": "1998", "unstructured": "Wang ZG, Ruggero D, Ronchetti S, Zhong S, Gaboli M, Rivi R et al. (1998). PML is essential for multiple apoptotic pathways. Nat Genet 20: 266\u2013272.", "journal-title": "Nat Genet"}, {"key": "BFonc2008305_CR95", "doi-asserted-by": "crossref", "first-page": "29288", "DOI": "10.1074/jbc.M212215200", "volume": "278", "author": "X Wei", "year": "2003", "unstructured": "Wei X, Yu ZK, Ramalingam A, Grossman SR, Yu JH, Bloch DB et al. (2003). Physical and functional interactions between PML and MDM2. J Biol Chem 278: 29288\u201329297.", "journal-title": "J Biol Chem"}, {"key": "BFonc2008305_CR96", "doi-asserted-by": "crossref", "first-page": "12294", "DOI": "10.1074/jbc.M211849200", "volume": "278", "author": "WS Wu", "year": "2003", "unstructured": "Wu WS, Xu ZX, Hittelman WN, Salomoni P, Pandolfi PP, Chang KS . (2003). Promyelocytic leukemia protein sensitizes tumor necrosis factor alpha-induced apoptosis by inhibiting the NF-kappaB survival pathway. J Biol Chem 278: 12294\u201312304.", "journal-title": "J Biol Chem"}, {"key": "BFonc2008305_CR97", "doi-asserted-by": "crossref", "first-page": "26645", "DOI": "10.1074/jbc.M604391200", "volume": "281", "author": "S Yang", "year": "2006", "unstructured": "Yang S, Jeong JH, Brown AL, Lee CH, Pandolfi PP, Chung JH et al. (2006). Promyelocytic leukemia activates Chk2 by mediating Chk2 autophosphorylation. J Biol Chem 281: 26645\u201326654.", "journal-title": "J Biol Chem"}, {"key": "BFonc2008305_CR98", "doi-asserted-by": "crossref", "first-page": "865", "DOI": "10.1038/ncb869", "volume": "4", "author": "S Yang", "year": "2002", "unstructured": "Yang S, Kuo C, Bisi JE, Kim MK . (2002). PML-dependent apoptosis after DNA damage is regulated by the checkpoint kinase hCds1/Chk2. Nat Cell Biol 4: 865\u2013870.", "journal-title": "Nat Cell Biol"}, {"key": "BFonc2008305_CR99", "doi-asserted-by": "crossref", "first-page": "1067", "DOI": "10.1016/S0092-8674(00)80294-9", "volume": "89", "author": "X Yang", "year": "1997", "unstructured": "Yang X, Khosravi-Far R, Chang HY, Baltimore D . (1997). Daxx, a novel Fas-binding protein that activates JNK and apoptosis. Cell 89: 1067\u20131076.", "journal-title": "Cell"}, {"key": "BFonc2008305_CR100", "doi-asserted-by": "crossref", "first-page": "273", "DOI": "10.1128/MCB.02422-06", "volume": "27", "author": "H Yoshida", "year": "2007", "unstructured": "Yoshida H, Ichikawa H, Tagata Y, Katsumoto T, Ohnishi K, Akao Y et al. (2007). PML-RARA inhibits PML IV enhancement of PU.1-induced C/EBP{epsilon} expression in myeloid differentiation. Mol Cell Biol 27: 273\u2013280.", "journal-title": "Mol Cell Biol"}, {"key": "BFonc2008305_CR101", "first-page": "2748", "volume": "95", "author": "S Zhong", "year": "2000", "unstructured": "Zhong S, Muller S, Ronchetti S, Freemont PS, Dejean A, Pandolfi PP . (2000a). Role of SUMO-1-modified PML in nuclear body formation. Blood 95: 2748\u20132752.", "journal-title": "Blood"}, {"key": "BFonc2008305_CR102", "doi-asserted-by": "crossref", "first-page": "E85", "DOI": "10.1038/35010583", "volume": "2", "author": "S Zhong", "year": "2000", "unstructured": "Zhong S, Salomoni P, Pandolfi PP . (2000b). The transcriptional role of PML and the nuclear body. Nat Cell Biol 2: E85\u2013E90.", "journal-title": "Nat Cell Biol"}, {"key": "BFonc2008305_CR103", "doi-asserted-by": "crossref", "first-page": "631", "DOI": "10.1084/jem.191.4.631", "volume": "191", "author": "S Zhong", "year": "2000", "unstructured": "Zhong S, Salomoni P, Ronchetti S, Guo A, Ruggero D, Pandolfi PP . (2000c). Promyelocytic leukemia protein (PML) and Daxx participate in a novel nuclear pathway for apoptosis. J Exp Med 191: 631\u2013640.", "journal-title": "J Exp Med"}, {"key": "BFonc2008305_CR104", "doi-asserted-by": "crossref", "first-page": "49286", "DOI": "10.1074/jbc.M308302200", "volume": "278", "author": "H Zhu", "year": "2003", "unstructured": "Zhu H, Wu L, Maki CG . (2003). MDM2 and promyelocytic leukemia antagonize each other through their direct interaction with p53. J Biol Chem 278: 49286\u201349292.", "journal-title": "J Biol Chem"}], "container-title": ["Oncogene"], "language": "en", "link": [{"URL": "http://www.nature.com/articles/onc2008305.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/onc2008305", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/onc2008305.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 4, 18]], "date-time": "2019-04-18T17:00:11Z", "timestamp": 1555606811000}, "score": 32.21855, "issued": {"date-parts": [[2008, 10]]}, "references-count": 104, "journal-issue": {"published-print": {"date-parts": [[2008, 10]]}, "issue": "48"}, "alternative-id": ["BFonc2008305"], "URL": "http://dx.doi.org/10.1038/onc.2008.305", "relation": {"cites": []}, "ISSN": ["0950-9232", "1476-5594"], "issn-type": [{"value": "0950-9232", "type": "print"}, {"value": "1476-5594", "type": "electronic"}], "subject": ["Genetics", "Cancer Research", "Molecular Biology"]}, {"indexed": {"date-parts": [[2019, 12, 5]], "date-time": "2019-12-05T07:22:02Z", "timestamp": 1575530522499}, "reference-count": 30, "publisher": "American Society of Hematology", "issue": "5", "content-domain": {"domain": ["ashpublications.org"], "crossmark-restriction": true}, "published-print": {"date-parts": [[1998, 9, 1]]}, "abstract": "<jats:p>Inorganic arsenic trioxide (As2O3) and the organic arsenical, melarsoprol, were recently shown to inhibit growth and induce apoptosis in NB4 acute promyelocytic leukemia (APL) and chronic B-cell leukemia cell lines, respectively. As2O3 has been proposed to principally target PML and PML-RAR\ue700 proteins in APL cells. We investigated the activity of As2O3 and melarsoprol in a broader context encompassing various myeloid leukemia cell lines, including the APL cell line NB4-306 (a retinoic acid\u2013resistant cell line derived from NB4 that no longer expresses the intact PML-RAR\ue700 fusion protein), HL60, KG-1, and the myelomonocytic cell line U937. To examine the role of PML in mediating arsenical activity, we also tested these agents using murine embryonic fibroblasts (MEFs) and bone marrow (BM) progenitors in which the PML gene had been inactivated by homologous recombination. Unexpectedly, we found that both compounds inhibited cell growth, induced apoptosis, and downregulated bcl-2 protein in all cell lines tested. Melarsoprol was more potent than As2O3 at equimolar concentrations ranging from 10\u22127 to 10\u22125 mol/L. As2O3 relocalized PML and PML-RAR\ue700 onto nuclear bodies, which was followed by PML degradation in NB4 as well as in HL60 and U937 cell lines. Although melarsoprol was more potent in inhibiting growth and inducing apoptosis, it did not affect PML and/or PML-RAR\ue700 nuclear localization. Moreover, both As2O3 and melarsoprol comparably inhibited growth and induced apoptosis of PML+/+ and PML\u2212/\u2212 MEFs, and inhibited colony-forming unit erythroid (CFU-E) and CFU granulocyte-monocyte formation in BM cultures of PML+/+ and PML\u2212/\u2212 progenitors. Together, these results show that As2O3 and melarsoprol inhibit growth and induce apoptosis independent of both PML and PML-RAR\ue700 expression in a variety of myeloid leukemia cell lines, and suggest that these agents may be more broadly used for treatment of leukemias other than APL.</jats:p>\n               <jats:p>\u00a9 1998 by The American Society of Hematology.</jats:p>", "DOI": "10.1182/blood.v92.5.1497.417k41_1497_1504", "type": "journal-article", "created": {"date-parts": [[2019, 10, 13]], "date-time": "2019-10-13T14:02:20Z", "timestamp": 1570975340000}, "page": "1497-1504", "update-policy": "http://dx.doi.org/10.1182/blood.2019cm0000", "source": "Crossref", "is-referenced-by-count": 2, "title": ["Arsenic Trioxide and Melarsoprol Induce Programmed Cell Death in Myeloid Leukemia Cell Lines and Function in a PML and PML-RAR\ue700 Independent Manner"], "prefix": "10.1182", "volume": "92", "author": [{"given": "Zhu-Gang", "family": "Wang", "sequence": "first", "affiliation": [{"name": "From the Department of Human Genetics, Molecular Biology Program, and the Molecular Therapeutics Program, the Sloan-Kettering Institute, Graduate School of Medical Sciences, Cornell University, New York, NY; the Leukemia and Developmental Chemotherapy Services, the Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY; and the Istituto Nazionale Tumori, Milan, Italy."}]}, {"given": "Roberta", "family": "Rivi", "sequence": "additional", "affiliation": [{"name": "From the Department of Human Genetics, Molecular Biology Program, and the Molecular Therapeutics Program, the Sloan-Kettering Institute, Graduate School of Medical Sciences, Cornell University, New York, NY; the Leukemia and Developmental Chemotherapy Services, the Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY; and the Istituto Nazionale Tumori, Milan, Italy."}]}, {"given": "Laurent", "family": "Delva", "sequence": "additional", "affiliation": [{"name": "From the Department of Human Genetics, Molecular Biology Program, and the Molecular Therapeutics Program, the Sloan-Kettering Institute, Graduate School of Medical Sciences, Cornell University, New York, NY; the Leukemia and Developmental Chemotherapy Services, the Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY; and the Istituto Nazionale Tumori, Milan, Italy."}]}, {"given": "Andrea", "family": "Ko\u0308nig", "sequence": "additional", "affiliation": [{"name": "From the Department of Human Genetics, Molecular Biology Program, and the Molecular Therapeutics Program, the Sloan-Kettering Institute, Graduate School of Medical Sciences, Cornell University, New York, NY; the Leukemia and Developmental Chemotherapy Services, the Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY; and the Istituto Nazionale Tumori, Milan, Italy."}]}, {"given": "David A.", "family": "Scheinberg", "sequence": "additional", "affiliation": [{"name": "From the Department of Human Genetics, Molecular Biology Program, and the Molecular Therapeutics Program, the Sloan-Kettering Institute, Graduate School of Medical Sciences, Cornell University, New York, NY; the Leukemia and Developmental Chemotherapy Services, the Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY; and the Istituto Nazionale Tumori, Milan, Italy."}]}, {"given": "Carlo", "family": "Gambacorti-Passerini", "sequence": "additional", "affiliation": [{"name": "From the Department of Human Genetics, Molecular Biology Program, and the Molecular Therapeutics Program, the Sloan-Kettering Institute, Graduate School of Medical Sciences, Cornell University, New York, NY; the Leukemia and Developmental Chemotherapy Services, the Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY; and the Istituto Nazionale Tumori, Milan, Italy."}]}, {"given": "Janice L.", "family": "Gabrilove", "sequence": "additional", "affiliation": [{"name": "From the Department of Human Genetics, Molecular Biology Program, and the Molecular Therapeutics Program, the Sloan-Kettering Institute, Graduate School of Medical Sciences, Cornell University, New York, NY; the Leukemia and Developmental Chemotherapy Services, the Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY; and the Istituto Nazionale Tumori, Milan, Italy."}]}, {"suffix": "Jr", "given": "Raymond P.", "family": "Warrell", "sequence": "additional", "affiliation": [{"name": "From the Department of Human Genetics, Molecular Biology Program, and the Molecular Therapeutics Program, the Sloan-Kettering Institute, Graduate School of Medical Sciences, Cornell University, New York, NY; the Leukemia and Developmental Chemotherapy Services, the Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY; and the Istituto Nazionale Tumori, Milan, Italy."}]}, {"given": "Pier Paolo", "family": "Pandolfi", "sequence": "additional", "affiliation": [{"name": "From the Department of Human Genetics, Molecular Biology Program, and the Molecular Therapeutics Program, the Sloan-Kettering Institute, Graduate School of Medical Sciences, Cornell University, New York, NY; the Leukemia and Developmental Chemotherapy Services, the Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY; and the Istituto Nazionale Tumori, Milan, Italy."}]}], "member": "234", "reference": [{"key": "2019112003184774700_B1", "first-page": "37", "article-title": "Arsenoxide in relation to the toxicity and therapeutic activity of arsphenamine and neoarsphenamine.", "volume": "18", "author": "Schamberg", "year": "1934", "journal-title": "Am J Syph Neurol"}, {"key": "2019112003184774700_B2", "doi-asserted-by": "crossref", "first-page": "153", "DOI": "10.1016/0001-706X(93)90089-T", "article-title": "Current situation of African trypanosomiasis.", "volume": "54", "author": "Kuzoe", "year": "1993", "journal-title": "Acta Trop"}, {"key": "2019112003184774700_B3", "first-page": "305", "article-title": "Arsenic as a therapeutic agent in chronic myeloid leukemia.", "volume": "97", "author": "Forkner", "year": "1931", "journal-title": "JAMA"}, {"key": "2019112003184774700_B4", "first-page": "170", "article-title": "Ai-Lin I treated 32 cases of acute promyelocytic leukemia.", "volume": "12", "author": "Sun", "year": "1992", "journal-title": "Chin J Integrat Chin West Med"}, {"key": "2019112003184774700_B5", "doi-asserted-by": "crossref", "first-page": "3354", "DOI": "10.1182/blood.V89.9.3354", "article-title": "Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients.", "volume": "89", "author": "Shen", "year": "1997", "journal-title": "Blood"}, {"key": "2019112003184774700_B6", "first-page": "6a", "article-title": "Initial Western study of arsenic trioxide (As2O3) in acute promyelocytic leukemia.", "volume": "17", "author": "Warrell RP Jr", "year": "1998", "journal-title": "Proc Am Soc Clin Oncol"}, {"key": "2019112003184774700_B7", "first-page": "1285", "article-title": "Structure and origin of the acute promyelocytic leukemia myl/RAR\u03b1 cDNA and characterization of its retinoid-binding and transactivation properties.", "volume": "6", "author": "Pandolfi", "year": "1991", "journal-title": "Oncogene"}, {"key": "2019112003184774700_B8", "doi-asserted-by": "crossref", "first-page": "663", "DOI": "10.1016/0092-8674(91)90112-C", "article-title": "Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RAR\u03b1 with a novel putative transcription factor, PML.", "volume": "66", "author": "Kakizuka", "year": "1991", "journal-title": "Cell"}, {"key": "2019112003184774700_B9", "doi-asserted-by": "crossref", "first-page": "675", "DOI": "10.1016/0092-8674(91)90113-D", "article-title": "The PML/RAR\u03b1 fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR.", "volume": "66", "author": "de The\u0300", "year": "1991", "journal-title": "Cell"}, {"key": "2019112003184774700_B10", "doi-asserted-by": "crossref", "first-page": "1397", "DOI": "10.1002/j.1460-2075.1992.tb05185.x", "article-title": "Genomic variability and alternative splicing generate multiple PML/RAR\u03b1 transcripts that encode aberrant PML proteins and PML/RAR\u03b1 isoforms in acute promyelocytic leukemia.", "volume": "11", "author": "Pandolfi", "year": "1992", "journal-title": "EMBO J"}, {"key": "2019112003184774700_B11", "doi-asserted-by": "crossref", "first-page": "1052", "DOI": "10.1182/blood.V88.3.1052.1052", "article-title": "In vitro studies on cellular and molecular mechanisms of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia: As2O3 induces NB4 cell apoptosis with downregulation of Bcl-2 expression and modulation of PML-RAR\u03b1/PML proteins.", "volume": "88", "author": "Chen", "year": "1996", "journal-title": "Blood"}, {"key": "2019112003184774700_B12", "doi-asserted-by": "crossref", "first-page": "3978", "DOI": "10.1073/pnas.94.8.3978", "article-title": "Arsenic-induced PML targeting onto nuclear bodies: Implications for the treatment of acute promyelocytic leukemia.", "volume": "94", "author": "Zhu", "year": "1997", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "2019112003184774700_B13", "doi-asserted-by": "crossref", "first-page": "124", "DOI": "10.1093/jnci/90.2.124", "article-title": "Arsenic trioxide as an inducer of apoptosis and loss of PML/RAR\u03b1 protein in acute promyelocytic leukemia cells.", "volume": "90", "author": "Shao", "year": "1998", "journal-title": "J Natl Cancer Inst"}, {"key": "2019112003184774700_B14", "doi-asserted-by": "crossref", "first-page": "86", "DOI": "10.1093/jnci/90.2.86", "article-title": "Arsenic and Apoptosis in the treatment of acute promyelocytic leukemia.", "volume": "90", "author": "Look", "year": "1998", "journal-title": "J Natl Cancer Inst"}, {"key": "2019112003184774700_B15", "doi-asserted-by": "crossref", "first-page": "562", "DOI": "10.1182/blood.V90.2.562.562_562_570", "article-title": "Comparative activity of melarsoprol and arsenic trioxide in chronic B-cell leukemia lines.", "volume": "90", "author": "Ko\u0308nig", "year": "1997", "journal-title": "Blood"}, {"key": "2019112003184774700_B16", "first-page": "261a", "article-title": "Targeted disruption of the PML gene of acute promyelocytic leukemia.", "volume": "86", "author": "Pandolfi", "year": "1995", "journal-title": "Blood"}, {"key": "2019112003184774700_B17", "first-page": "477a", "article-title": "Growth and tumor suppressive properties of the PML gene of acute promyelocytic leukemia in PML-/- mice.", "volume": "88", "author": "Wang", "year": "1996", "journal-title": "Blood"}, {"key": "2019112003184774700_B18", "doi-asserted-by": "crossref", "first-page": "1547", "DOI": "10.1126/science.279.5356.1547", "article-title": "Role of PML in cell growth and the retinoic acid pathway.", "volume": "297", "author": "Wang", "year": "1998", "journal-title": "Science"}, {"key": "2019112003184774700_B19", "doi-asserted-by": "crossref", "first-page": "493", "DOI": "10.1083/jcb.119.3.493", "article-title": "Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.", "volume": "119", "author": "Gavrieli", "year": "1992", "journal-title": "J Cell Biol"}, {"key": "2019112003184774700_B20", "doi-asserted-by": "crossref", "first-page": "1939", "DOI": "10.1182/blood.V87.5.1939.bloodjournal8751939", "article-title": "Retinoid-induced differentation of acute promyelocytic leukemia involves PML-RAR\u03b1\u2013mediated increase of type II transglutaminase.", "volume": "87", "author": "Benedetti", "year": "1996", "journal-title": "Blood"}, {"key": "2019112003184774700_B21", "author": "Dupuy-Coin", "first-page": "5", "year": "1974", "article-title": "Localization of nuclear functions as revealed by ultrastructural autoradiography and cytochemistry", "volume-title": "The Cell Nucleus."}, {"key": "2019112003184774700_B22", "doi-asserted-by": "crossref", "first-page": "785", "DOI": "10.1083/jcb.112.5.785", "article-title": "Identification of a novel nuclear domain.", "volume": "112", "author": "Ascoli", "year": "1991", "journal-title": "J Cell Biol"}, {"key": "2019112003184774700_B23", "doi-asserted-by": "crossref", "first-page": "1073", "DOI": "10.1002/j.1460-2075.1994.tb06356.x", "article-title": "The t(15;17) translocation alters a nuclear body in a retinoic acid-reversible fashion.", "volume": "13", "author": "Koken", "year": "1994", "journal-title": "EMBO J"}, {"key": "2019112003184774700_B24", "doi-asserted-by": "crossref", "first-page": "333", "DOI": "10.1016/0092-8674(94)90340-9", "article-title": "A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein.", "volume": "76", "author": "Dyck", "year": "1994", "journal-title": "Cell"}, {"key": "2019112003184774700_B25", "doi-asserted-by": "crossref", "first-page": "345", "DOI": "10.1016/0092-8674(94)90341-7", "article-title": "Retinoic acid regulates aberrant nuclear localization of PML-RARalpha in acute promyelocytic leukemic cells.", "volume": "76", "author": "Weis", "year": "1994", "journal-title": "Cell"}, {"key": "2019112003184774700_B26", "first-page": "227", "article-title": "Cytotoxcity of arsenic trioxide in cancer cell lines.", "volume": "39", "author": "Yang", "year": "1998", "journal-title": "Proc Am Assoc Cancer Res"}, {"key": "2019112003184774700_B27", "first-page": "3636", "article-title": "Arsenic trioxide induces apoptosis in K562 chronic myelogenous leukemia (CML) cells.", "volume": "90", "author": "Calleja", "year": "1997", "journal-title": "Blood"}, {"key": "2019112003184774700_B28", "first-page": "218a", "article-title": "Arsenic trioxide inhibits cell survival in a variety of cancer cell types.", "volume": "17", "author": "Calleja", "year": "1998", "journal-title": "Proc Am Soc Clin Oncol"}, {"key": "2019112003184774700_B29", "first-page": "507a", "article-title": "Melarsoprol, an organic arsenical, in the treatment of refractory leukemia: Laboratory and clinical results.", "volume": "90", "author": "Soignet", "year": "1997", "journal-title": "Blood"}, {"key": "2019112003184774700_B30", "first-page": "3859a", "article-title": "Response and toxicity associated with dose escalation of arsenic trioxide in the treatment of resistant acute promyelocytic leukemia.", "volume": "90", "author": "Westervelt", "year": "1997", "journal-title": "Blood"}], "container-title": ["Blood"], "language": "en", "link": [{"URL": "https://ashpublications.org/blood/article/92/5/1497/51423/Arsenic-Trioxide-and-Melarsoprol-Induce-Programmed", "content-type": "application/pdf", "content-version": "vor", "intended-application": "syndication"}, {"URL": "https://ashpublications.org/blood/article/92/5/1497/51423/Arsenic-Trioxide-and-Melarsoprol-Induce-Programmed", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T08:28:13Z", "timestamp": 1574238493000}, "score": 31.887928, "issued": {"date-parts": [[1998, 9, 1]]}, "references-count": 30, "journal-issue": {"published-print": {"date-parts": [[1998, 9, 1]]}, "issue": "5"}, "URL": "http://dx.doi.org/10.1182/blood.v92.5.1497.417k41_1497_1504", "relation": {"cites": []}, "ISSN": ["1528-0020", "0006-4971"], "issn-type": [{"value": "0006-4971", "type": "print"}, {"value": "1528-0020", "type": "electronic"}], "subject": ["Immunology", "Cell Biology", "Biochemistry", "Hematology"]}, {"indexed": {"date-parts": [[2019, 12, 5]], "date-time": "2019-12-05T07:33:20Z", "timestamp": 1575531200592}, "reference-count": 30, "publisher": "American Society of Hematology", "issue": "5", "content-domain": {"domain": ["ashpublications.org"], "crossmark-restriction": true}, "published-print": {"date-parts": [[1998, 9, 1]]}, "abstract": "<jats:title>Abstract</jats:title>\n               <jats:p>Inorganic arsenic trioxide (As2O3) and the organic arsenical, melarsoprol, were recently shown to inhibit growth and induce apoptosis in NB4 acute promyelocytic leukemia (APL) and chronic B-cell leukemia cell lines, respectively. As2O3 has been proposed to principally target PML and PML-RAR\ue700 proteins in APL cells. We investigated the activity of As2O3 and melarsoprol in a broader context encompassing various myeloid leukemia cell lines, including the APL cell line NB4-306 (a retinoic acid\u2013resistant cell line derived from NB4 that no longer expresses the intact PML-RAR\ue700 fusion protein), HL60, KG-1, and the myelomonocytic cell line U937. To examine the role of PML in mediating arsenical activity, we also tested these agents using murine embryonic fibroblasts (MEFs) and bone marrow (BM) progenitors in which the PML gene had been inactivated by homologous recombination. Unexpectedly, we found that both compounds inhibited cell growth, induced apoptosis, and downregulated bcl-2 protein in all cell lines tested. Melarsoprol was more potent than As2O3 at equimolar concentrations ranging from 10\u22127 to 10\u22125 mol/L. As2O3 relocalized PML and PML-RAR\ue700 onto nuclear bodies, which was followed by PML degradation in NB4 as well as in HL60 and U937 cell lines. Although melarsoprol was more potent in inhibiting growth and inducing apoptosis, it did not affect PML and/or PML-RAR\ue700 nuclear localization. Moreover, both As2O3 and melarsoprol comparably inhibited growth and induced apoptosis of PML+/+ and PML\u2212/\u2212 MEFs, and inhibited colony-forming unit erythroid (CFU-E) and CFU granulocyte-monocyte formation in BM cultures of PML+/+ and PML\u2212/\u2212 progenitors. Together, these results show that As2O3 and melarsoprol inhibit growth and induce apoptosis independent of both PML and PML-RAR\ue700 expression in a variety of myeloid leukemia cell lines, and suggest that these agents may be more broadly used for treatment of leukemias other than APL.</jats:p>\n               <jats:p>\u00a9 1998 by The American Society of Hematology.</jats:p>", "DOI": "10.1182/blood.v92.5.1497", "type": "journal-article", "created": {"date-parts": [[2019, 10, 14]], "date-time": "2019-10-14T10:17:08Z", "timestamp": 1571048228000}, "page": "1497-1504", "update-policy": "http://dx.doi.org/10.1182/blood.2019cm0000", "source": "Crossref", "is-referenced-by-count": 17, "title": ["Arsenic Trioxide and Melarsoprol Induce Programmed Cell Death in Myeloid Leukemia Cell Lines and Function in a PML and PML-RAR\ue700 Independent Manner"], "prefix": "10.1182", "volume": "92", "author": [{"given": "Zhu-Gang", "family": "Wang", "sequence": "first", "affiliation": [{"name": "From the Department of Human Genetics, Molecular Biology Program, and the Molecular Therapeutics Program, the Sloan-Kettering Institute, Graduate School of Medical Sciences, Cornell University, New York, NY; the Leukemia and Developmental Chemotherapy Services, the Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY; and the Istituto Nazionale Tumori, Milan, Italy."}]}, {"given": "Roberta", "family": "Rivi", "sequence": "additional", "affiliation": [{"name": "From the Department of Human Genetics, Molecular Biology Program, and the Molecular Therapeutics Program, the Sloan-Kettering Institute, Graduate School of Medical Sciences, Cornell University, New York, NY; the Leukemia and Developmental Chemotherapy Services, the Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY; and the Istituto Nazionale Tumori, Milan, Italy."}]}, {"given": "Laurent", "family": "Delva", "sequence": "additional", "affiliation": [{"name": "From the Department of Human Genetics, Molecular Biology Program, and the Molecular Therapeutics Program, the Sloan-Kettering Institute, Graduate School of Medical Sciences, Cornell University, New York, NY; the Leukemia and Developmental Chemotherapy Services, the Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY; and the Istituto Nazionale Tumori, Milan, Italy."}]}, {"given": "Andrea", "family": "Ko\u0308nig", "sequence": "additional", "affiliation": [{"name": "From the Department of Human Genetics, Molecular Biology Program, and the Molecular Therapeutics Program, the Sloan-Kettering Institute, Graduate School of Medical Sciences, Cornell University, New York, NY; the Leukemia and Developmental Chemotherapy Services, the Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY; and the Istituto Nazionale Tumori, Milan, Italy."}]}, {"given": "David A.", "family": "Scheinberg", "sequence": "additional", "affiliation": [{"name": "From the Department of Human Genetics, Molecular Biology Program, and the Molecular Therapeutics Program, the Sloan-Kettering Institute, Graduate School of Medical Sciences, Cornell University, New York, NY; the Leukemia and Developmental Chemotherapy Services, the Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY; and the Istituto Nazionale Tumori, Milan, Italy."}]}, {"given": "Carlo", "family": "Gambacorti-Passerini", "sequence": "additional", "affiliation": [{"name": "From the Department of Human Genetics, Molecular Biology Program, and the Molecular Therapeutics Program, the Sloan-Kettering Institute, Graduate School of Medical Sciences, Cornell University, New York, NY; the Leukemia and Developmental Chemotherapy Services, the Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY; and the Istituto Nazionale Tumori, Milan, Italy."}]}, {"given": "Janice L.", "family": "Gabrilove", "sequence": "additional", "affiliation": [{"name": "From the Department of Human Genetics, Molecular Biology Program, and the Molecular Therapeutics Program, the Sloan-Kettering Institute, Graduate School of Medical Sciences, Cornell University, New York, NY; the Leukemia and Developmental Chemotherapy Services, the Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY; and the Istituto Nazionale Tumori, Milan, Italy."}]}, {"suffix": "Jr", "given": "Raymond P.", "family": "Warrell", "sequence": "additional", "affiliation": [{"name": "From the Department of Human Genetics, Molecular Biology Program, and the Molecular Therapeutics Program, the Sloan-Kettering Institute, Graduate School of Medical Sciences, Cornell University, New York, NY; the Leukemia and Developmental Chemotherapy Services, the Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY; and the Istituto Nazionale Tumori, Milan, Italy."}]}, {"given": "Pier Paolo", "family": "Pandolfi", "sequence": "additional", "affiliation": [{"name": "From the Department of Human Genetics, Molecular Biology Program, and the Molecular Therapeutics Program, the Sloan-Kettering Institute, Graduate School of Medical Sciences, Cornell University, New York, NY; the Leukemia and Developmental Chemotherapy Services, the Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY; and the Istituto Nazionale Tumori, Milan, Italy."}]}], "member": "234", "reference": [{"key": "2019112009164162800_B1", "first-page": "37", "article-title": "Arsenoxide in relation to the toxicity and therapeutic activity of arsphenamine and neoarsphenamine.", "volume": "18", "author": "Schamberg", "year": "1934", "journal-title": "Am J Syph Neurol"}, {"key": "2019112009164162800_B2", "doi-asserted-by": "crossref", "first-page": "153", "DOI": "10.1016/0001-706X(93)90089-T", "article-title": "Current situation of African trypanosomiasis.", "volume": "54", "author": "Kuzoe", "year": "1993", "journal-title": "Acta Trop"}, {"key": "2019112009164162800_B3", "first-page": "305", "article-title": "Arsenic as a therapeutic agent in chronic myeloid leukemia.", "volume": "97", "author": "Forkner", "year": "1931", "journal-title": "JAMA"}, {"key": "2019112009164162800_B4", "first-page": "170", "article-title": "Ai-Lin I treated 32 cases of acute promyelocytic leukemia.", "volume": "12", "author": "Sun", "year": "1992", "journal-title": "Chin J Integrat Chin West Med"}, {"key": "2019112009164162800_B5", "doi-asserted-by": "crossref", "first-page": "3354", "DOI": "10.1182/blood.V89.9.3354", "article-title": "Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients.", "volume": "89", "author": "Shen", "year": "1997", "journal-title": "Blood"}, {"key": "2019112009164162800_B6", "first-page": "6a", "article-title": "Initial Western study of arsenic trioxide (As2O3) in acute promyelocytic leukemia.", "volume": "17", "author": "Warrell RP Jr", "year": "1998", "journal-title": "Proc Am Soc Clin Oncol"}, {"key": "2019112009164162800_B7", "first-page": "1285", "article-title": "Structure and origin of the acute promyelocytic leukemia myl/RAR\u03b1 cDNA and characterization of its retinoid-binding and transactivation properties.", "volume": "6", "author": "Pandolfi", "year": "1991", "journal-title": "Oncogene"}, {"key": "2019112009164162800_B8", "doi-asserted-by": "crossref", "first-page": "663", "DOI": "10.1016/0092-8674(91)90112-C", "article-title": "Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RAR\u03b1 with a novel putative transcription factor, PML.", "volume": "66", "author": "Kakizuka", "year": "1991", "journal-title": "Cell"}, {"key": "2019112009164162800_B9", "doi-asserted-by": "crossref", "first-page": "675", "DOI": "10.1016/0092-8674(91)90113-D", "article-title": "The PML/RAR\u03b1 fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR.", "volume": "66", "author": "de The\u0300", "year": "1991", "journal-title": "Cell"}, {"key": "2019112009164162800_B10", "doi-asserted-by": "crossref", "first-page": "1397", "DOI": "10.1002/j.1460-2075.1992.tb05185.x", "article-title": "Genomic variability and alternative splicing generate multiple PML/RAR\u03b1 transcripts that encode aberrant PML proteins and PML/RAR\u03b1 isoforms in acute promyelocytic leukemia.", "volume": "11", "author": "Pandolfi", "year": "1992", "journal-title": "EMBO J"}, {"key": "2019112009164162800_B11", "doi-asserted-by": "crossref", "first-page": "1052", "DOI": "10.1182/blood.V88.3.1052.1052", "article-title": "In vitro studies on cellular and molecular mechanisms of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia: As2O3 induces NB4 cell apoptosis with downregulation of Bcl-2 expression and modulation of PML-RAR\u03b1/PML proteins.", "volume": "88", "author": "Chen", "year": "1996", "journal-title": "Blood"}, {"key": "2019112009164162800_B12", "doi-asserted-by": "crossref", "first-page": "3978", "DOI": "10.1073/pnas.94.8.3978", "article-title": "Arsenic-induced PML targeting onto nuclear bodies: Implications for the treatment of acute promyelocytic leukemia.", "volume": "94", "author": "Zhu", "year": "1997", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "2019112009164162800_B13", "doi-asserted-by": "crossref", "first-page": "124", "DOI": "10.1093/jnci/90.2.124", "article-title": "Arsenic trioxide as an inducer of apoptosis and loss of PML/RAR\u03b1 protein in acute promyelocytic leukemia cells.", "volume": "90", "author": "Shao", "year": "1998", "journal-title": "J Natl Cancer Inst"}, {"key": "2019112009164162800_B14", "doi-asserted-by": "crossref", "first-page": "86", "DOI": "10.1093/jnci/90.2.86", "article-title": "Arsenic and Apoptosis in the treatment of acute promyelocytic leukemia.", "volume": "90", "author": "Look", "year": "1998", "journal-title": "J Natl Cancer Inst"}, {"key": "2019112009164162800_B15", "doi-asserted-by": "crossref", "first-page": "562", "DOI": "10.1182/blood.V90.2.562", "article-title": "Comparative activity of melarsoprol and arsenic trioxide in chronic B-cell leukemia lines.", "volume": "90", "author": "Ko\u0308nig", "year": "1997", "journal-title": "Blood"}, {"key": "2019112009164162800_B16", "first-page": "261a", "article-title": "Targeted disruption of the PML gene of acute promyelocytic leukemia.", "volume": "86", "author": "Pandolfi", "year": "1995", "journal-title": "Blood"}, {"key": "2019112009164162800_B17", "first-page": "477a", "article-title": "Growth and tumor suppressive properties of the PML gene of acute promyelocytic leukemia in PML-/- mice.", "volume": "88", "author": "Wang", "year": "1996", "journal-title": "Blood"}, {"key": "2019112009164162800_B18", "doi-asserted-by": "crossref", "first-page": "1547", "DOI": "10.1126/science.279.5356.1547", "article-title": "Role of PML in cell growth and the retinoic acid pathway.", "volume": "297", "author": "Wang", "year": "1998", "journal-title": "Science"}, {"key": "2019112009164162800_B19", "doi-asserted-by": "crossref", "first-page": "493", "DOI": "10.1083/jcb.119.3.493", "article-title": "Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.", "volume": "119", "author": "Gavrieli", "year": "1992", "journal-title": "J Cell Biol"}, {"key": "2019112009164162800_B20", "doi-asserted-by": "crossref", "first-page": "1939", "DOI": "10.1182/blood.V87.5.1939.1939", "article-title": "Retinoid-induced differentation of acute promyelocytic leukemia involves PML-RAR\u03b1\u2013mediated increase of type II transglutaminase.", "volume": "87", "author": "Benedetti", "year": "1996", "journal-title": "Blood"}, {"key": "2019112009164162800_B21", "author": "Dupuy-Coin", "first-page": "5", "year": "1974", "article-title": "Localization of nuclear functions as revealed by ultrastructural autoradiography and cytochemistry", "volume-title": "The Cell Nucleus."}, {"key": "2019112009164162800_B22", "doi-asserted-by": "crossref", "first-page": "785", "DOI": "10.1083/jcb.112.5.785", "article-title": "Identification of a novel nuclear domain.", "volume": "112", "author": "Ascoli", "year": "1991", "journal-title": "J Cell Biol"}, {"key": "2019112009164162800_B23", "doi-asserted-by": "crossref", "first-page": "1073", "DOI": "10.1002/j.1460-2075.1994.tb06356.x", "article-title": "The t(15;17) translocation alters a nuclear body in a retinoic acid-reversible fashion.", "volume": "13", "author": "Koken", "year": "1994", "journal-title": "EMBO J"}, {"key": "2019112009164162800_B24", "doi-asserted-by": "crossref", "first-page": "333", "DOI": "10.1016/0092-8674(94)90340-9", "article-title": "A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein.", "volume": "76", "author": "Dyck", "year": "1994", "journal-title": "Cell"}, {"key": "2019112009164162800_B25", "doi-asserted-by": "crossref", "first-page": "345", "DOI": "10.1016/0092-8674(94)90341-7", "article-title": "Retinoic acid regulates aberrant nuclear localization of PML-RARalpha in acute promyelocytic leukemic cells.", "volume": "76", "author": "Weis", "year": "1994", "journal-title": "Cell"}, {"key": "2019112009164162800_B26", "first-page": "227", "article-title": "Cytotoxcity of arsenic trioxide in cancer cell lines.", "volume": "39", "author": "Yang", "year": "1998", "journal-title": "Proc Am Assoc Cancer Res"}, {"key": "2019112009164162800_B27", "first-page": "3636", "article-title": "Arsenic trioxide induces apoptosis in K562 chronic myelogenous leukemia (CML) cells.", "volume": "90", "author": "Calleja", "year": "1997", "journal-title": "Blood"}, {"key": "2019112009164162800_B28", "first-page": "218a", "article-title": "Arsenic trioxide inhibits cell survival in a variety of cancer cell types.", "volume": "17", "author": "Calleja", "year": "1998", "journal-title": "Proc Am Soc Clin Oncol"}, {"key": "2019112009164162800_B29", "first-page": "507a", "article-title": "Melarsoprol, an organic arsenical, in the treatment of refractory leukemia: Laboratory and clinical results.", "volume": "90", "author": "Soignet", "year": "1997", "journal-title": "Blood"}, {"key": "2019112009164162800_B30", "first-page": "3859a", "article-title": "Response and toxicity associated with dose escalation of arsenic trioxide in the treatment of resistant acute promyelocytic leukemia.", "volume": "90", "author": "Westervelt", "year": "1997", "journal-title": "Blood"}], "container-title": ["Blood"], "language": "en", "link": [{"URL": "https://ashpublications.org/blood/article/92/5/1497/247389/Arsenic-Trioxide-and-Melarsoprol-Induce-Programmed", "content-type": "application/pdf", "content-version": "vor", "intended-application": "syndication"}, {"URL": "https://ashpublications.org/blood/article/92/5/1497/247389/Arsenic-Trioxide-and-Melarsoprol-Induce-Programmed", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T14:35:53Z", "timestamp": 1574260553000}, "score": 31.887928, "issued": {"date-parts": [[1998, 9, 1]]}, "references-count": 30, "journal-issue": {"published-print": {"date-parts": [[1998, 9, 1]]}, "issue": "5"}, "URL": "http://dx.doi.org/10.1182/blood.v92.5.1497", "relation": {"cites": []}, "ISSN": ["1528-0020", "0006-4971"], "issn-type": [{"value": "0006-4971", "type": "print"}, {"value": "1528-0020", "type": "electronic"}], "subject": ["Immunology", "Cell Biology", "Biochemistry", "Hematology"]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T07:29:23Z", "timestamp": 1574494163104}, "reference-count": 38, "publisher": "American Society of Hematology", "issue": "15", "content-domain": {"domain": ["ashpublications.org"], "crossmark-restriction": true}, "published-print": {"date-parts": [[2011, 4, 14]]}, "abstract": "<jats:title>Abstract</jats:title>\n               <jats:p>Acute promyelocytic leukemia (APL) is a distinct subtype of acute myeloid leukemia that results from the expression of the promyelocytic leukemia\u2013retinoic acid receptor \u03b1 (PML-RAR-\u03b1) oncoprotein. It is characterized by severe hemorrhagic complications due in part to excessive fibrinolysis, resulting from the excessive generation of the fibrinolytic enzyme, plasmin, at the cell surface of the PML cells. The treatment of patients with all-trans retinoic acid (ATRA) effectively ameliorates the disease by promoting the destruction of the PML-RAR-\u03b1 oncoprotein. In the present study we show for the first time that the plasminogen receptor, S100A10, is present on the extracellular surface of APL cells and is rapidly down-regulated in response to all-trans retinoic acid. The loss of S100A10 is concomitant with a loss in fibrinolytic activity. Furthermore, the induced expression of the PML-RAR-\u03b1 oncoprotein increased the expression of cell surface S100A10 and also caused a dramatic increase in fibrinolytic activity. Depletion of S100A10 by RNA interference effectively blocked the enhanced fibrinolytic activity observed after induction of the PML-RAR-\u03b1 oncoprotein. These experiments show that S100A10 plays a crucial role in the generation of plasmin leading to fibrinolysis, thus providing a link to the clinical hemorrhagic phenotype of APL.</jats:p>", "DOI": "10.1182/blood-2010-07-298851", "type": "journal-article", "created": {"date-parts": [[2011, 2, 11]], "date-time": "2011-02-11T05:20:24Z", "timestamp": 1297401624000}, "page": "4095-4105", "update-policy": "http://dx.doi.org/10.1182/blood.2019cm0000", "source": "Crossref", "is-referenced-by-count": 30, "title": ["Regulation of S100A10 by the PML-RAR-\u03b1 oncoprotein"], "prefix": "10.1182", "volume": "117", "author": [{"given": "Paul A.", "family": "O'Connell", "sequence": "first", "affiliation": [{"name": "Departments of Biochemistry and Molecular Biology,"}]}, {"given": "Patricia A.", "family": "Madureira", "sequence": "additional", "affiliation": [{"name": "Departments of Biochemistry and Molecular Biology,"}]}, {"given": "Jason N.", "family": "Berman", "sequence": "additional", "affiliation": [{"name": "Pediatrics,"}, {"name": "Microbiology and Immunology, and"}]}, {"given": "Robert S.", "family": "Liwski", "sequence": "additional", "affiliation": [{"name": "Pathology, Dalhousie University, Halifax, NS"}]}, {"given": "David M.", "family": "Waisman", "sequence": "additional", "affiliation": [{"name": "Departments of Biochemistry and Molecular Biology,"}]}], "member": "234", "reference": [{"issue": "3", "key": "2019111702591900300_B1", "doi-asserted-by": "crossref", "first-page": "543", "DOI": "10.1182/blood.V79.3.543.543", "article-title": "Reassessing the hemostatic disorder associated with acute promyelocytic leukemia.", "volume": "79", "author": "Tallman", "year": "1992", "journal-title": "Blood"}, {"issue": "1", "key": "2019111702591900300_B2", "doi-asserted-by": "crossref", "first-page": "10", "DOI": "10.1182/blood.V83.1.10.10", "article-title": "Acute promyelocytic leukemia: from genetics to treatment.", "volume": "83", "author": "Grignani", "year": "1994", "journal-title": "Blood"}, {"issue": "3", "key": "2019111702591900300_B3", "doi-asserted-by": "crossref", "first-page": "423", "DOI": "10.1016/0092-8674(93)80044-F", "article-title": "The acute promyelocytic leukemia-specific PML-RAR alpha fusion protein inhibits differentiation and promotes survival of myeloid precursor cells.", "volume": "74", "author": "Grignani", "year": "1993", "journal-title": "Cell"}, {"issue": "3", "key": "2019111702591900300_B4", "doi-asserted-by": "crossref", "first-page": "177", "DOI": "10.1056/NEJM199307153290307", "article-title": "Acute promyelocytic leukemia.", "volume": "329", "author": "Warrell", "year": "1993", "journal-title": "N Engl J Med"}, {"issue": "4", "key": "2019111702591900300_B5", "doi-asserted-by": "crossref", "first-page": "539", "DOI": "10.1046/j.1365-2141.2003.04460.x", "article-title": "The history of acute promyelocytic leukaemia.", "volume": "122", "author": "Degos", "year": "2003", "journal-title": "Br J Haematol"}, {"issue": "2", "key": "2019111702591900300_B6", "doi-asserted-by": "crossref", "first-page": "73", "DOI": "10.1159/000117712", "article-title": "A comprehensive review of acute promyelocytic leukemia in children.", "volume": "119", "author": "Mantadakis", "year": "2008", "journal-title": "Acta Haematol"}, {"issue": "5", "key": "2019111702591900300_B7", "doi-asserted-by": "crossref", "first-page": "867", "DOI": "10.1016/S0889-8588(05)70256-2", "article-title": "Retinoid therapy of childhood cancer.", "volume": "15", "author": "Reynolds", "year": "2001", "journal-title": "Hematol Oncol Clin North Am"}, {"issue": "1", "key": "2019111702591900300_B8", "doi-asserted-by": "crossref", "first-page": "153", "DOI": "10.1016/j.beha.2008.12.007", "article-title": "The coagulopathy of acute promyelocytic leukaemia revisited.", "volume": "22", "author": "Stein", "year": "2009", "journal-title": "Best Pract Res Clin Haematol"}, {"issue": "8", "key": "2019111702591900300_B9", "doi-asserted-by": "crossref", "first-page": "1341", "DOI": "10.1111/j.1538-7836.2004.00787.x", "article-title": "Effects of all-trans retinoic acid or chemotherapy on the molecular regulation of systemic blood coagulation and fibrinolysis in patients with acute promyelocytic leukemia.", "volume": "2", "author": "Tallman", "year": "2004", "journal-title": "J Thromb Haemost"}, {"issue": "6", "key": "2019111702591900300_B10", "doi-asserted-by": "crossref", "first-page": "906", "DOI": "10.1055/s-0037-1613942", "article-title": "Elastase mediated fibrinolysis in acute promyelocytic leukemia.", "volume": "83", "author": "Oudijk", "year": "2000", "journal-title": "Thromb Haemost"}, {"issue": "1", "key": "2019111702591900300_B11", "first-page": "2", "article-title": "Coagulation disorders associated with acute promyelocytic leukemia: corrective effect of all-trans retinoic acid treatment.", "volume": "7", "author": "Dombret", "year": "1993", "journal-title": "Leukemia"}, {"issue": "1", "key": "2019111702591900300_B12", "first-page": "19", "article-title": "In vivo thrombin and plasmin activities in patients with acute promyelocytic leukemia (APL): effect of all-trans retinoic acid (ATRA) therapy.", "volume": "9", "author": "Dombret", "year": "1995", "journal-title": "Leukemia"}, {"issue": "1", "key": "2019111702591900300_B13", "doi-asserted-by": "crossref", "first-page": "43", "DOI": "10.1111/j.1365-2141.1988.tb02432.x", "article-title": "Acquired alpha-2-antiplasmin deficiency in acute promyelocytic leukaemia.", "volume": "70", "author": "Avvisati", "year": "1988", "journal-title": "Br J Haematol"}, {"issue": "2", "key": "2019111702591900300_B14", "first-page": "126", "article-title": "Evidence of fibrinogen breakdown by leukocyte enzymes in a patient with acute promyelocytic leukemia.", "volume": "15", "author": "Sterrenberg", "year": "1985", "journal-title": "Haemostasis"}, {"issue": "9", "key": "2019111702591900300_B15", "doi-asserted-by": "crossref", "first-page": "1949", "DOI": "10.1182/blood.V77.9.1949.1949", "article-title": "The specific activity of plasminogen activator inhibitor-1 in disseminated intravascular coagulation with acute promyelocytic leukemia.", "volume": "77", "author": "Sakata", "year": "1991", "journal-title": "Blood"}, {"issue": "8", "key": "2019111702591900300_B16", "doi-asserted-by": "crossref", "first-page": "4790", "DOI": "10.1074/jbc.273.8.4790", "article-title": "The role of annexin II tetramer in the activation of plasminogen.", "volume": "273", "author": "Kassam", "year": "1998", "journal-title": "J Biol Chem"}, {"issue": "7", "key": "2019111702591900300_B17", "doi-asserted-by": "crossref", "first-page": "637", "DOI": "10.1016/S1357-2725(01)00046-2", "article-title": "S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles.", "volume": "33", "author": "Donato", "year": "2001", "journal-title": "Int J Biochem Cell Biol"}, {"issue": "28", "key": "2019111702591900300_B18", "doi-asserted-by": "crossref", "first-page": "25577", "DOI": "10.1074/jbc.M301017200", "article-title": "Phospholipid-associated annexin A2-S100A10 heterotetramer and its subunits: characterization of the interaction with tissue plasminogen activator, plasminogen, and plasmin.", "volume": "278", "author": "MacLeod", "year": "2003", "journal-title": "J Biol Chem"}, {"issue": "48", "key": "2019111702591900300_B19", "doi-asserted-by": "crossref", "first-page": "16958", "DOI": "10.1021/bi981713l", "article-title": "The p11 subunit of the annexin II tetramer plays a key role in the stimulation of t-PA-dependent plasminogen activation.", "volume": "37", "author": "Kassam", "year": "1998", "journal-title": "Biochemistry"}, {"issue": "15", "key": "2019111702591900300_B20", "doi-asserted-by": "crossref", "first-page": "4953", "DOI": "10.1021/bi012045y", "article-title": "The p11 subunit of annexin II heterotetramer is regulated by basic carboxypeptidase.", "volume": "41", "author": "Fogg", "year": "2002", "journal-title": "Biochemistry"}, {"issue": "2", "key": "2019111702591900300_B21", "doi-asserted-by": "crossref", "first-page": "235", "DOI": "10.1096/fj.02-0697com", "article-title": "p11 regulates extracellular plasmin production and invasiveness of HT1080 fibrosarcoma cells.", "volume": "17", "author": "Choi", "year": "2003", "journal-title": "FASEB J"}, {"issue": "8", "key": "2019111702591900300_B22", "doi-asserted-by": "crossref", "first-page": "2826", "DOI": "10.1182/blood.V88.8.2826.bloodjournal8882826", "article-title": "The PML/RAR alpha oncoprotein is a direct molecular target of retinoic acid in acute promyelocytic leukemia cells.", "volume": "88", "author": "Raelson", "year": "1996", "journal-title": "Blood"}, {"issue": "2", "key": "2019111702591900300_B23", "doi-asserted-by": "crossref", "first-page": "258", "DOI": "10.1111/j.1365-2141.2005.05750.x", "article-title": "All-trans retinoic acid-induced downregulation of annexin II expression in myeloid leukaemia cell lines is not confined to acute promyelocytic leukaemia.", "volume": "131", "author": "Olwill", "year": "2005", "journal-title": "Br J Haematol"}, {"issue": "18", "key": "2019111702591900300_B24", "doi-asserted-by": "crossref", "first-page": "4949", "DOI": "10.1002/j.1460-2075.1996.tb00875.x", "article-title": "Effects on differentiation by the promyelocytic leukemia PML/RARalpha protein depend on the fusion of the PML protein dimerization and RARalpha DNA binding domains.", "volume": "15", "author": "Grignani", "year": "1996", "journal-title": "EMBO J"}, {"issue": "9", "key": "2019111702591900300_B25", "doi-asserted-by": "crossref", "first-page": "1875", "DOI": "10.1182/blood-2008-04-150250", "article-title": "Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet.", "volume": "113", "author": "Sanz", "year": "2009", "journal-title": "Blood"}, {"key": "2019111702591900300_B26", "first-page": "1754", "article-title": "Plasminogen receptors: the sine qua non of cell surface plasminogen activation.", "volume": "10", "author": "Miles", "year": "2005", "journal-title": "Front Biosci"}, {"issue": "6", "key": "2019111702591900300_B27", "doi-asserted-by": "crossref", "first-page": "1682", "DOI": "10.1021/bi00220a034", "article-title": "Role of cell-surface lysines in plasminogen binding to cells: identification of alpha-enolase as a candidate plasminogen receptor.", "volume": "30", "author": "Miles", "year": "1991", "journal-title": "Biochemistry"}, {"issue": "1", "key": "2019111702591900300_B28", "doi-asserted-by": "crossref", "first-page": "179", "DOI": "10.1074/jbc.M004919200", "article-title": "Purification, cloning, and characterization of a profibrinolytic plasminogen-binding protein, TIP49a.", "volume": "276", "author": "Hawley", "year": "2001", "journal-title": "J Biol Chem"}, {"issue": "4", "key": "2019111702591900300_B29", "doi-asserted-by": "crossref", "first-page": "1582", "DOI": "10.1182/blood-2002-06-1842", "article-title": "Convergence of the adhesive and fibrinolytic systems: recognition of urokinase by integrin alpha Mbeta 2 as well as by the urokinase receptor regulates cell adhesion and migration.", "volume": "101", "author": "Pluskota", "year": "2003", "journal-title": "Blood"}, {"issue": "10", "key": "2019111702591900300_B30", "doi-asserted-by": "crossref", "first-page": "3763", "DOI": "10.1182/blood-2007-03-079392", "article-title": "Histone H2B as a functionally important plasminogen receptor on macrophages.", "volume": "110", "author": "Das", "year": "2007", "journal-title": "Blood"}, {"issue": "13", "key": "2019111702591900300_B31", "doi-asserted-by": "crossref", "first-page": "994", "DOI": "10.1056/NEJM199904013401303", "article-title": "Annexin II and bleeding in acute promyelocytic leukemia.", "volume": "340", "author": "Menell", "year": "1999", "journal-title": "N Engl J Med"}, {"issue": "7", "key": "2019111702591900300_B32", "doi-asserted-by": "crossref", "first-page": "1136", "DOI": "10.1182/blood-2010-01-264754", "article-title": "S100A10 regulates plasminogen-dependent macrophage invasion.", "volume": "116", "author": "O'Connell", "year": "2010", "journal-title": "Blood"}, {"issue": "8", "key": "2019111702591900300_B33", "doi-asserted-by": "crossref", "first-page": "3342", "DOI": "10.1182/blood-2005-07-2840", "article-title": "Identification of the annexin A2 heterotetramer as a receptor for the plasmin-induced signaling in human peripheral monocytes.", "volume": "107", "author": "Laumonnier", "year": "2006", "journal-title": "Blood"}, {"issue": "5", "key": "2019111702591900300_B34", "doi-asserted-by": "crossref", "first-page": "1125", "DOI": "10.1016/S0006-291X(02)02043-0", "article-title": "Differential gene expression in retinoic acid-induced differentiation of acute promyelocytic leukemia cells, NB4 and HL-60 cells.", "volume": "296", "author": "Lee", "year": "2002", "journal-title": "Biochem Biophys Res Commun"}, {"key": "2019111702591900300_B35", "doi-asserted-by": "crossref", "first-page": "300", "DOI": "10.2741/1529", "article-title": "S100A10, annexin A2, and annexin a2 heterotetramer as candidate plasminogen receptors.", "volume": "10", "author": "Kwon", "year": "2005", "journal-title": "Front Biosci"}, {"issue": "33", "key": "2019111702591900300_B36", "first-page": "21198", "article-title": "An endothelial cell receptor for plasminogen/tissue plasminogen activator (t-PA), II: annexin II-mediated enhancement of t-PA-dependent plasminogen activation.", "volume": "269", "author": "Cesarman", "year": "1994", "journal-title": "J Biol Chem"}, {"issue": "5", "key": "2019111702591900300_B37", "doi-asserted-by": "crossref", "first-page": "128", "DOI": "10.1016/S1050-1738(99)00020-1", "article-title": "Annexin II: a mediator of the plasmin/plasminogen activator system.", "volume": "9", "author": "Hajjar", "year": "1999", "journal-title": "Trends Cardiovasc Med"}, {"key": "2019111702591900300_B38", "doi-asserted-by": "crossref", "first-page": "d341", "DOI": "10.2741/kim", "article-title": "Annexin II: a plasminogen-plasminogen activator co-receptor.", "volume": "7", "author": "Kim", "year": "2002", "journal-title": "Front Biosci"}], "container-title": ["Blood"], "language": "en", "link": [{"URL": "http://ashpublications.org/blood/article-pdf/117/15/4095/1462671/zh801511004095.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "syndication"}, {"URL": "http://ashpublications.org/blood/article-pdf/117/15/4095/1462671/zh801511004095.pdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 11, 17]], "date-time": "2019-11-17T07:59:32Z", "timestamp": 1573977572000}, "score": 31.564545, "issued": {"date-parts": [[2011, 4, 14]]}, "references-count": 38, "journal-issue": {"published-print": {"date-parts": [[2011, 4, 14]]}, "issue": "15"}, "URL": "http://dx.doi.org/10.1182/blood-2010-07-298851", "relation": {"cites": []}, "ISSN": ["0006-4971", "1528-0020"], "issn-type": [{"value": "0006-4971", "type": "print"}, {"value": "1528-0020", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T06:39:34Z", "timestamp": 1574145574127}, "reference-count": 0, "publisher": "Elsevier BV", "issue": "5-7", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1992, 1, 1]], "date-time": "1992-01-01T00:00:00Z", "timestamp": 694224000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Biomedicine & Pharmacotherapy"], "published-print": {"date-parts": [[1992, 1]]}, "DOI": "10.1016/0753-3322(92)90197-f", "type": "journal-article", "created": {"date-parts": [[2002, 12, 14]], "date-time": "2002-12-14T02:56:22Z", "timestamp": 1039834582000}, "page": "294", "source": "Crossref", "is-referenced-by-count": 0, "title": ["112. PML-RAR. A fusion protein in human acute promyelocytic leukemia"], "prefix": "10.1016", "volume": "46", "author": [{"given": "A", "family": "Kakizuka", "sequence": "first", "affiliation": []}, {"given": "JA", "family": "Dyck", "sequence": "additional", "affiliation": []}, {"given": "RM", "family": "Evans", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Biomedicine & Pharmacotherapy"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:075333229290197F?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:075333229290197F?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 4, 1]], "date-time": "2019-04-01T21:56:01Z", "timestamp": 1554155761000}, "score": 31.512402, "issued": {"date-parts": [[1992, 1]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1992, 1]]}, "issue": "5-7"}, "alternative-id": ["075333229290197F"], "URL": "http://dx.doi.org/10.1016/0753-3322(92)90197-f", "ISSN": ["0753-3322"], "issn-type": [{"value": "0753-3322", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T00:32:50Z", "timestamp": 1574209970851}, "reference-count": 0, "publisher": "Proceedings of the National Academy of Sciences", "issue": "11", "content-domain": {"domain": ["pnas.org"], "crossmark-restriction": true}, "short-container-title": ["Proceedings of the National Academy of Sciences"], "published-print": {"date-parts": [[1992, 6, 1]]}, "DOI": "10.1073/pnas.89.11.4840", "type": "journal-article", "created": {"date-parts": [[2006, 5, 31]], "date-time": "2006-05-31T12:01:47Z", "timestamp": 1149076907000}, "page": "4840-4844", "update-policy": "http://dx.doi.org/10.1073/pnas.cm10313", "source": "Crossref", "is-referenced-by-count": 91, "title": ["Expression pattern of the RAR alpha-PML fusion gene in acute promyelocytic leukemia."], "prefix": "10.1073", "volume": "89", "author": [{"given": "M.", "family": "Alcalay", "sequence": "first", "affiliation": []}, {"given": "D.", "family": "Zangrilli", "sequence": "additional", "affiliation": []}, {"given": "M.", "family": "Fagioli", "sequence": "additional", "affiliation": []}, {"given": "P. P.", "family": "Pandolfi", "sequence": "additional", "affiliation": []}, {"given": "A.", "family": "Mencarelli", "sequence": "additional", "affiliation": []}, {"given": "F.", "family": "Lo Coco", "sequence": "additional", "affiliation": []}, {"given": "A.", "family": "Biondi", "sequence": "additional", "affiliation": []}, {"given": "F.", "family": "Grignani", "sequence": "additional", "affiliation": []}, {"given": "P. G.", "family": "Pelicci", "sequence": "additional", "affiliation": []}], "member": "341", "container-title": ["Proceedings of the National Academy of Sciences"], "language": "en", "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1073/pnas.89.11.4840", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 3, 30]], "date-time": "2017-03-30T21:40:22Z", "timestamp": 1490910022000}, "score": 29.669266, "issued": {"date-parts": [[1992, 6, 1]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1992, 6, 1]]}, "issue": "11"}, "URL": "http://dx.doi.org/10.1073/pnas.89.11.4840", "ISSN": ["0027-8424", "1091-6490"], "issn-type": [{"value": "0027-8424", "type": "print"}, {"value": "1091-6490", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T17:43:00Z", "timestamp": 1574444580949}, "publisher-location": "Berlin, Heidelberg", "reference-count": 12, "publisher": "Springer Berlin Heidelberg", "isbn-type": [{"value": "9783642719622", "type": "print"}, {"value": "9783642719608", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[1998]]}, "DOI": "10.1007/978-3-642-71960-8_144", "type": "book-chapter", "created": {"date-parts": [[2012, 1, 16]], "date-time": "2012-01-16T10:02:16Z", "timestamp": 1326708136000}, "page": "1031-1036", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Monitoring of PML-RAR alpha in Patients with Acute Promyelocytic Leukemia (APL) by RT-PCR"], "prefix": "10.1007", "author": [{"given": "A.", "family": "Reichert", "sequence": "first", "affiliation": []}, {"given": "E.", "family": "Lengfelder", "sequence": "additional", "affiliation": []}, {"given": "W.", "family": "Seifarth", "sequence": "additional", "affiliation": []}, {"given": "A.", "family": "Hochhaus", "sequence": "additional", "affiliation": []}, {"given": "S.", "family": "Saussele", "sequence": "additional", "affiliation": []}, {"given": "M.", "family": "Simon", "sequence": "additional", "affiliation": []}, {"given": "Th.", "family": "B\u00fcchner", "sequence": "additional", "affiliation": []}, {"given": "Ch.", "family": "Fonatsch", "sequence": "additional", "affiliation": []}, {"given": "H.", "family": "L\u00f6ffler", "sequence": "additional", "affiliation": []}, {"given": "W. D.", "family": "Ludwig", "sequence": "additional", "affiliation": []}, {"given": "R.", "family": "Hehlmann", "sequence": "additional", "affiliation": []}], "member": "297", "reference": [{"key": "144_CR1", "doi-asserted-by": "publisher", "first-page": "588", "DOI": "10.1038/347588a0", "volume": "347", "author": "TH Ide", "year": "1990", "unstructured": "Ide The H, Chomienne C, Lanotte M, Degos L, Dejean A (1990) The t(15;17) translocation of acute promyelocytic leukemia fuses the retinoic acid receptor alpha gene to a novel transcribed locus. Nature 347: 588", "journal-title": "Nature"}, {"key": "144_CR2", "doi-asserted-by": "publisher", "first-page": "1577", "DOI": "10.1126/science.2218500", "volume": "249", "author": "J Borrow", "year": "1990", "unstructured": "Borrow J, Goddard AD, Sheer D, Solomon E (1990) Molecular analysis of acute promyelocytic leukemia breakpoint cluster region on chromosome 17. Science 249: 1577", "journal-title": "Science"}, {"key": "144_CR3", "doi-asserted-by": "publisher", "first-page": "675", "DOI": "10.1016/0092-8674(91)90113-D", "volume": "66", "author": "H The de", "year": "1991", "unstructured": "de The H, Lavau C, Marchio A, Chomienne C, Degos L, Dejean A (1991) The PML-RAR alpha fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR. Cell 66: 675\u2013684", "journal-title": "Cell"}, {"key": "144_CR4", "doi-asserted-by": "publisher", "first-page": "663", "DOI": "10.1016/0092-8674(91)90112-C", "volume": "66", "author": "A Kakizuka", "year": "1991", "unstructured": "Kakizuka A, Miller WH, Umesono K, Warrell RP, Frankel SR, Murty VV, Dmitrovsky E, Evans RM (1991) Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RAR alpha with a novel putative transcription factor, PML. Cell 66: 663\u2013674", "journal-title": "Cell"}, {"key": "144_CR5", "doi-asserted-by": "publisher", "first-page": "332", "DOI": "10.1002/gcc.2870030503", "volume": "3", "author": "R Berger", "year": "1991", "unstructured": "Berger R, Le Coniat M, Derre J, Vecchione D, Jonveaux P (1991) Cytogenetic studies in acute promyelocytic leukemia. Genes Chromosome Cancer 3: 332", "journal-title": "Genes Chromosome Cancer"}, {"key": "144_CR6", "doi-asserted-by": "publisher", "first-page": "2694", "DOI": "10.1073/pnas.89.7.2694", "volume": "89", "author": "WH Miller Jr", "year": "1992", "unstructured": "Miller WH Jr, Kakizuka A, Frankel SR, Warrel RP Jr, De Blasio A, Levine K, Evans RM, Dmitrovsky E (1992) Reverse transcription polymerase chain reaction for the rearranged retinoic acid receptor alpha clarifies diagnosis and detects minimal residual disease in acute promyelocytic leukemia. Proc Natl Acad Sci USA 89: 2694", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "144_CR7", "first-page": "3110", "volume": "79", "author": "S Castaigne", "year": "1992", "unstructured": "Castaigne S, Balitrand N, de The H, Dejean A, Degos L, Chomienne C (1992) A PML/retinoic acid receptor alpha fusion transcript is constantly detected by RNA-based polymerase chain reaction in acute promyelocytic leukemia. Blood 79: 3110", "journal-title": "Blood"}, {"key": "144_CR8", "doi-asserted-by": "publisher", "first-page": "3", "DOI": "10.1097/00001622-199601000-00002", "volume": "8", "author": "P Fenaux", "year": "1996", "unstructured": "Fenaux P, Chomienne C (1996) Biology and treatment of acute promyelocytic leukemia. Curr Opin Oncol 8: 3\u201312", "journal-title": "Curr Opin Oncol"}, {"key": "144_CR9", "unstructured": "Lengfelder E, Seifarth W, Hehlmann R, L\u00f6ffler H, Fonatsch CH, Ludwig WD, Staib P, W\u00f6rmann B, Hiddemann W, Sauerland MC, Heinecke A, B\u00fcchner T (1997) All-Trans Retinoic Acid (ATRA) Combined with Double Induction Strategy in Acute Promyelocytic Leukemia (APL). Preliminary Results. 277 Ann Hematol 74 (Suppl 1) A 47"}, {"key": "144_CR10", "doi-asserted-by": "publisher", "first-page": "67", "DOI": "10.1111/j.1365-2141.1993.tb03026.x", "volume": "84", "author": "NCP Cross", "year": "1993", "unstructured": "Cross NCP, Hughes TP, Lin F, O\u2019Shea P, Bungey J, Marks DI, Ferrant P, Martiat P, Goldman JM (1993) Minimal residual disease after allogeneic bone marrow transplantation for chronic myeloid leukemia in first chronic phase: correlations with acute graft-versus -host disease and relapse. Br J Hematol 84: 67", "journal-title": "Br J Hematol"}, {"key": "144_CR11", "first-page": "1549", "volume": "87", "author": "A Hochhaus", "year": "1996", "unstructured": "Hochhaus A, Lin F, Reiter A, Skladny H, Mason PJ, van Rhee F, Shepherd PCA, Allan NC, Hehl-mann R, Goldman JM, Cross NCP (1996) Quantification of residual disease in chronic myelogenous leukemia patients on Interferon alpha therapy by competitive polymerase chain reaction. Blood 87: 1549\u20131555", "journal-title": "Blood"}, {"key": "144_CR12", "first-page": "329", "volume": "9", "author": "F Rhee Van", "year": "1995", "unstructured": "Van Rhee F, Marks DI, Lin F, Szydlo RM, Treleaven J, Hochhaus A, Delord C, Cross NCP, Goldman JM (1995) Quantification of residual disease in Philadelphia positive acute lymphoblastic leukemia: Comparison of blood and bone marrow. Leukemia 9: 329", "journal-title": "Leukemia"}], "container-title": ["Haematology and Blood Transfusion / H\u00e4matologie und Bluttransfusion", "Acute Leukemias VII"], "link": [{"URL": "http://www.springerlink.com/index/pdf/10.1007/978-3-642-71960-8_144", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 11, 4]], "date-time": "2019-11-04T21:25:12Z", "timestamp": 1572902712000}, "score": 29.669266, "issued": {"date-parts": [[1998]]}, "ISBN": ["9783642719622", "9783642719608"], "references-count": 12, "URL": "http://dx.doi.org/10.1007/978-3-642-71960-8_144", "relation": {"cites": []}, "ISSN": ["0440-0607"], "issn-type": [{"value": "0440-0607", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T18:55:40Z", "timestamp": 1574276140384}, "reference-count": 0, "publisher": "American Association for Cancer Research (AACR)", "issue": "3", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Cancer Research"], "DOI": "10.1158/0008-5472.can-08-2603", "type": "journal-article", "created": {"date-parts": [[2009, 1, 21]], "date-time": "2009-01-21T01:45:30Z", "timestamp": 1232502330000}, "page": "1016-1026", "source": "Crossref", "is-referenced-by-count": 40, "title": ["Inhibition of the Peptidyl-Prolyl-Isomerase Pin1 Enhances the Responses of Acute Myeloid Leukemia Cells to Retinoic Acid via Stabilization of RAR\u00a0 and PML-RAR\u00a0"], "prefix": "10.1158", "volume": "69", "author": [{"given": "M.", "family": "Gianni'", "sequence": "first", "affiliation": []}, {"given": "A.", "family": "Boldetti", "sequence": "additional", "affiliation": []}, {"given": "V.", "family": "Guarnaccia", "sequence": "additional", "affiliation": []}, {"given": "A.", "family": "Rambaldi", "sequence": "additional", "affiliation": []}, {"given": "E.", "family": "Parrella", "sequence": "additional", "affiliation": []}, {"given": "I.", "family": "Raska", "sequence": "additional", "affiliation": []}, {"given": "C.", "family": "Rochette-Egly", "sequence": "additional", "affiliation": []}, {"given": "G.", "family": "Del Sal", "sequence": "additional", "affiliation": []}, {"given": "A.", "family": "Rustighi", "sequence": "additional", "affiliation": []}, {"given": "M.", "family": "Terao", "sequence": "additional", "affiliation": []}, {"given": "E.", "family": "Garattini", "sequence": "additional", "affiliation": []}], "member": "1086", "published-online": {"date-parts": [[2009, 1, 20]]}, "container-title": ["Cancer Research"], "language": "en", "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1158/0008-5472.CAN-08-2603", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 23]], "date-time": "2016-12-23T14:13:50Z", "timestamp": 1482502430000}, "score": 29.502066, "issued": {"date-parts": [[2009, 1, 20]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2009, 1, 20]]}, "issue": "3"}, "URL": "http://dx.doi.org/10.1158/0008-5472.can-08-2603", "ISSN": ["0008-5472", "1538-7445"], "issn-type": [{"value": "0008-5472", "type": "print"}, {"value": "1538-7445", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 12, 5]], "date-time": "2019-12-05T07:28:01Z", "timestamp": 1575530881950}, "reference-count": 0, "publisher": "American Society of Hematology", "issue": "6", "content-domain": {"domain": ["ashpublications.org"], "crossmark-restriction": true}, "published-print": {"date-parts": [[1993, 9, 15]]}, "abstract": "<jats:title>Abstract</jats:title>\n               <jats:p>The characteristic reciprocal translocation t(15;17) of acute promyelocytic leukemia (APL) disrupts the PML gene on chromosome 15 and the retinoic acid receptor-alpha (RAR-alpha) gene on chromosome 17. PML/RAR-alpha fusion mRNAs are then transcribed and can be detected by a newly described reverse transcription polymerase chain reaction (RT- PCR) assay. Using RT followed by nested PCR amplification for PML/RAR- alpha, we serially evaluated bone marrow aspirates from patients with APL who were treated with all-trans retinoic acid (RA) for induction, followed by all-trans RA as maintenance or cytotoxic drugs as consolidation. At diagnosis, PML/RAR-alpha mRNA was detected in all patients. After initial therapy with all-trans RA, the RT-PCR assay remained positive after induction of complete remission in 31 of 32 evaluable patients. Maintenance treatment by all-trans RA alone was associated with persistent assay positivity and subsequent clinical relapse in 13 of 13 patients. By contrast, the test became negative in 19 of 20 newly diagnosed patients who received consolidation chemotherapy; the 1 patient who remained positive relapsed at 12 months. Three of the 19 assay-negative patients later converted to positive and subsequently relapsed; the remaining 16 patients have remained RT-PCR negative in sustained first remission, with a median follow-up duration that exceeds 24 months (range, 12+ to 34+ months). Despite induction of complete remission in a high proportion of patients, all-trans RA rarely eradicates molecular evidence of disease in patients with APL; however, subsequent treatment with cytotoxic chemotherapy frequently converts the RT-PCR assay for PML/RAR-alpha to negative. Serial negative tests are associated with prolonged disease- free survival, whereas persistence of a positive test after treatment is highly correlated with subsequent relapse. This test identifies patients in remission at high risk for relapse who may benefit from additional antileukemic therapy.</jats:p>", "DOI": "10.1182/blood.v82.6.1689.1689", "type": "journal-article", "created": {"date-parts": [[2019, 10, 14]], "date-time": "2019-10-14T02:56:05Z", "timestamp": 1571021765000}, "page": "1689-1694", "update-policy": "http://dx.doi.org/10.1182/blood.2019cm0000", "source": "Crossref", "is-referenced-by-count": 21, "title": ["Detection of minimal residual disease in acute promyelocytic leukemia by a reverse transcription polymerase chain reaction assay for the PML/RAR-alpha fusion mRNA"], "prefix": "10.1182", "volume": "82", "author": [{"given": "WH Jr", "family": "Miller", "sequence": "first", "affiliation": [{"name": "Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY"}]}, {"given": "K", "family": "Levine", "sequence": "additional", "affiliation": [{"name": "Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY"}]}, {"given": "A", "family": "DeBlasio", "sequence": "additional", "affiliation": [{"name": "Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY"}]}, {"given": "SR", "family": "Frankel", "sequence": "additional", "affiliation": [{"name": "Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY"}]}, {"given": "E", "family": "Dmitrovsky", "sequence": "additional", "affiliation": [{"name": "Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY"}]}, {"given": "RP Jr", "family": "Warrell", "sequence": "additional", "affiliation": [{"name": "Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY"}]}], "member": "234", "container-title": ["Blood"], "language": "en", "link": [{"URL": "http://ashpublications.org/blood/article-pdf/82/6/1689/611209/1689.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "syndication"}, {"URL": "http://ashpublications.org/blood/article-pdf/82/6/1689/611209/1689.pdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T06:19:44Z", "timestamp": 1574230784000}, "score": 29.479034, "issued": {"date-parts": [[1993, 9, 15]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1993, 9, 15]]}, "issue": "6"}, "URL": "http://dx.doi.org/10.1182/blood.v82.6.1689.1689", "ISSN": ["0006-4971", "1528-0020"], "issn-type": [{"value": "0006-4971", "type": "print"}, {"value": "1528-0020", "type": "electronic"}], "subject": ["Immunology", "Cell Biology", "Biochemistry", "Hematology"]}, {"indexed": {"date-parts": [[2019, 12, 5]], "date-time": "2019-12-05T07:19:27Z", "timestamp": 1575530367105}, "reference-count": 0, "publisher": "American Society of Hematology", "issue": "6", "content-domain": {"domain": ["ashpublications.org"], "crossmark-restriction": true}, "published-print": {"date-parts": [[1993, 9, 15]]}, "abstract": "<jats:p>The characteristic reciprocal translocation t(15;17) of acute promyelocytic leukemia (APL) disrupts the PML gene on chromosome 15 and the retinoic acid receptor-alpha (RAR-alpha) gene on chromosome 17. PML/RAR-alpha fusion mRNAs are then transcribed and can be detected by a newly described reverse transcription polymerase chain reaction (RT- PCR) assay. Using RT followed by nested PCR amplification for PML/RAR- alpha, we serially evaluated bone marrow aspirates from patients with APL who were treated with all-trans retinoic acid (RA) for induction, followed by all-trans RA as maintenance or cytotoxic drugs as consolidation. At diagnosis, PML/RAR-alpha mRNA was detected in all patients. After initial therapy with all-trans RA, the RT-PCR assay remained positive after induction of complete remission in 31 of 32 evaluable patients. Maintenance treatment by all-trans RA alone was associated with persistent assay positivity and subsequent clinical relapse in 13 of 13 patients. By contrast, the test became negative in 19 of 20 newly diagnosed patients who received consolidation chemotherapy; the 1 patient who remained positive relapsed at 12 months. Three of the 19 assay-negative patients later converted to positive and subsequently relapsed; the remaining 16 patients have remained RT-PCR negative in sustained first remission, with a median follow-up duration that exceeds 24 months (range, 12+ to 34+ months). Despite induction of complete remission in a high proportion of patients, all-trans RA rarely eradicates molecular evidence of disease in patients with APL; however, subsequent treatment with cytotoxic chemotherapy frequently converts the RT-PCR assay for PML/RAR-alpha to negative. Serial negative tests are associated with prolonged disease- free survival, whereas persistence of a positive test after treatment is highly correlated with subsequent relapse. This test identifies patients in remission at high risk for relapse who may benefit from additional antileukemic therapy.</jats:p>", "DOI": "10.1182/blood.v82.6.1689.bloodjournal8261689", "type": "journal-article", "created": {"date-parts": [[2019, 10, 13]], "date-time": "2019-10-13T08:09:13Z", "timestamp": 1570954153000}, "page": "1689-1694", "update-policy": "http://dx.doi.org/10.1182/blood.2019cm0000", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Detection of minimal residual disease in acute promyelocytic leukemia by a reverse transcription polymerase chain reaction assay for the PML/RAR-alpha fusion mRNA"], "prefix": "10.1182", "volume": "82", "author": [{"given": "WH Jr", "family": "Miller", "sequence": "first", "affiliation": [{"name": "Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY"}]}, {"given": "K", "family": "Levine", "sequence": "additional", "affiliation": [{"name": "Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY"}]}, {"given": "A", "family": "DeBlasio", "sequence": "additional", "affiliation": [{"name": "Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY"}]}, {"given": "SR", "family": "Frankel", "sequence": "additional", "affiliation": [{"name": "Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY"}]}, {"given": "E", "family": "Dmitrovsky", "sequence": "additional", "affiliation": [{"name": "Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY"}]}, {"given": "RP Jr", "family": "Warrell", "sequence": "additional", "affiliation": [{"name": "Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY"}]}], "member": "234", "container-title": ["Blood"], "language": "en", "link": [{"URL": "http://ashpublications.org/blood/article-pdf/82/6/1689/229184/1689.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "syndication"}, {"URL": "http://ashpublications.org/blood/article-pdf/82/6/1689/229184/1689.pdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T03:41:53Z", "timestamp": 1574221313000}, "score": 29.479034, "issued": {"date-parts": [[1993, 9, 15]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1993, 9, 15]]}, "issue": "6"}, "URL": "http://dx.doi.org/10.1182/blood.v82.6.1689.bloodjournal8261689", "ISSN": ["0006-4971", "1528-0020"], "issn-type": [{"value": "0006-4971", "type": "print"}, {"value": "1528-0020", "type": "electronic"}], "subject": ["Immunology", "Cell Biology", "Biochemistry", "Hematology"]}, {"indexed": {"date-parts": [[2019, 12, 5]], "date-time": "2019-12-05T07:02:31Z", "timestamp": 1575529351992}, "reference-count": 0, "publisher": "American Society of Hematology", "issue": "8", "content-domain": {"domain": ["ashpublications.org"], "crossmark-restriction": true}, "published-print": {"date-parts": [[1996, 10, 15]]}, "abstract": "<jats:p>Acute promyelocytic leukemia (APL) is characterized by the translocation, t(15;17) and the expression of a PML/RAR alpha fusion protein that is diagnostic of the disease. There is evidence that PML/RAR alpha protein acts as a dominant negative inhibitor of normal retinoid receptor function and myeloid differentiation. We now show that the PML/RAR alpha fusion product is directly downregulated in response to retinoic acid (tRA) treatment in the human APL cell line, NB4. tRA treatment induces loss of PML/RAR alpha at the protein level but not at the level of mRNA, as determined by Northern blots, by Western blots, and by ligand binding assays and in binding to RA-responsive DNA elements. We present evidence that this regulation is posttranslational. This evidence suggests that tRA induces synthesis of a protein that selectively degrades PML/RAR alpha. We further show that this loss of PML/ RAR-alpha is not limited to the unique APL cell line. NB4, because PML/RAR alpha protein is selectively downregulated by tRA when expressed in the transfected myeloid cell line U937. The loss of PML/RAR alpha may be directly linked to tRA-induced differentiation, because in a retinoid-resistant subclone of NB4, tRA does not decrease PML/RAR alpha protein expression. In NB4 cells, the specific downregulation of the fusion protein decreases the ratio of PML/RAR alpha to wild-type RAR alpha. Because the ratio of expression of PML/RAR alpha to wild-type RAR alpha and PML may be important in maintaining the dominant negative block of myelocytic differentiation, these data suggest a molecular mechanism for restoration by tRA normal myeloid differentiation in APL cells.</jats:p>", "DOI": "10.1182/blood.v88.8.2826.bloodjournal8882826", "type": "journal-article", "created": {"date-parts": [[2019, 10, 11]], "date-time": "2019-10-11T20:54:55Z", "timestamp": 1570827295000}, "page": "2826-2832", "update-policy": "http://dx.doi.org/10.1182/blood.2019cm0000", "source": "Crossref", "is-referenced-by-count": 42, "title": ["The PML/RAR alpha oncoprotein is a direct molecular target of retinoic acid in acute promyelocytic leukemia cells"], "prefix": "10.1182", "volume": "88", "author": [{"given": "JV", "family": "Raelson", "sequence": "first", "affiliation": [{"name": "Lady Davis Institute for Medical Research, Sir Mortimer Davis Jewish General Hospital, Montreal, Quebec, Canada."}]}, {"given": "C", "family": "Nervi", "sequence": "additional", "affiliation": [{"name": "Lady Davis Institute for Medical Research, Sir Mortimer Davis Jewish General Hospital, Montreal, Quebec, Canada."}]}, {"given": "A", "family": "Rosenauer", "sequence": "additional", "affiliation": [{"name": "Lady Davis Institute for Medical Research, Sir Mortimer Davis Jewish General Hospital, Montreal, Quebec, Canada."}]}, {"given": "L", "family": "Benedetti", "sequence": "additional", "affiliation": [{"name": "Lady Davis Institute for Medical Research, Sir Mortimer Davis Jewish General Hospital, Montreal, Quebec, Canada."}]}, {"given": "Y", "family": "Monczak", "sequence": "additional", "affiliation": [{"name": "Lady Davis Institute for Medical Research, Sir Mortimer Davis Jewish General Hospital, Montreal, Quebec, Canada."}]}, {"given": "M", "family": "Pearson", "sequence": "additional", "affiliation": [{"name": "Lady Davis Institute for Medical Research, Sir Mortimer Davis Jewish General Hospital, Montreal, Quebec, Canada."}]}, {"given": "PG", "family": "Pelicci", "sequence": "additional", "affiliation": [{"name": "Lady Davis Institute for Medical Research, Sir Mortimer Davis Jewish General Hospital, Montreal, Quebec, Canada."}]}, {"given": "WH Jr", "family": "Miller", "sequence": "additional", "affiliation": [{"name": "Lady Davis Institute for Medical Research, Sir Mortimer Davis Jewish General Hospital, Montreal, Quebec, Canada."}]}], "member": "234", "container-title": ["Blood"], "language": "en", "link": [{"URL": "http://ashpublications.org/blood/article-pdf/88/8/2826/623127/2826.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "syndication"}, {"URL": "http://ashpublications.org/blood/article-pdf/88/8/2826/623127/2826.pdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 11, 18]], "date-time": "2019-11-18T00:25:29Z", "timestamp": 1574036729000}, "score": 29.252308, "issued": {"date-parts": [[1996, 10, 15]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1996, 10, 15]]}, "issue": "8"}, "URL": "http://dx.doi.org/10.1182/blood.v88.8.2826.bloodjournal8882826", "ISSN": ["0006-4971", "1528-0020"], "issn-type": [{"value": "0006-4971", "type": "print"}, {"value": "1528-0020", "type": "electronic"}], "subject": ["Immunology", "Cell Biology", "Biochemistry", "Hematology"]}, {"indexed": {"date-parts": [[2019, 11, 18]], "date-time": "2019-11-18T22:48:39Z", "timestamp": 1574117319856}, "reference-count": 45, "publisher": "Proceedings of the National Academy of Sciences", "issue": "17", "content-domain": {"domain": ["pnas.org"], "crossmark-restriction": true}, "short-container-title": ["Proceedings of the National Academy of Sciences"], "published-print": {"date-parts": [[1997, 8, 19]]}, "DOI": "10.1073/pnas.94.17.9028", "type": "journal-article", "created": {"date-parts": [[2002, 7, 26]], "date-time": "2002-07-26T14:35:50Z", "timestamp": 1027694150000}, "page": "9028-9033", "update-policy": "http://dx.doi.org/10.1073/pnas.cm10313", "source": "Crossref", "is-referenced-by-count": 210, "title": ["SMRT corepressor interacts with PLZF and with the PML-retinoic acid receptor \u00a0 (RAR\u00a0) and PLZF-RAR\u00a0 oncoproteins associated with acute promyelocytic leukemia"], "prefix": "10.1073", "volume": "94", "author": [{"given": "S.-H.", "family": "Hong", "sequence": "first", "affiliation": []}, {"given": "G.", "family": "David", "sequence": "additional", "affiliation": []}, {"given": "C.-W.", "family": "Wong", "sequence": "additional", "affiliation": []}, {"given": "A.", "family": "Dejean", "sequence": "additional", "affiliation": []}, {"given": "M. L.", "family": "Privalsky", "sequence": "additional", "affiliation": []}], "member": "341", "reference": [{"key": "1_39507718", "volume": "14", "first-page": "184", "year": "1993", "journal-title": "ENDOCRINOL REV"}, {"issue": "1", "key": "2_15680747", "doi-asserted-by": "publisher", "first-page": "451", "DOI": "10.1146/annurev.bi.63.070194.002315", "volume": "63", "author": "Tsai", "year": "1994", "journal-title": "Annual review of biochemistry", "ISSN": "http://id.crossref.org/issn/0066-4154", "issn-type": "print"}, {"issue": "6", "key": "3_16118255", "doi-asserted-by": "publisher", "first-page": "835", "DOI": "10.1016/0092-8674(95)90199-X", "volume": "83", "author": "Mangelsdorf", "year": "1995", "journal-title": "Cell", "ISSN": "http://id.crossref.org/issn/0092-8674", "issn-type": "print"}, {"issue": "6", "key": "4_16118256", "doi-asserted-by": "publisher", "first-page": "841", "DOI": "10.1016/0092-8674(95)90200-7", "volume": "83", "author": "Mangelsdorf", "year": "1995", "journal-title": "Cell", "ISSN": "http://id.crossref.org/issn/0092-8674", "issn-type": "print"}, {"issue": "6", "key": "5_16118257", "doi-asserted-by": "publisher", "first-page": "851", "DOI": "10.1016/0092-8674(95)90201-5", "volume": "83", "author": "Beato", "year": "1995", "journal-title": "Cell", "ISSN": "http://id.crossref.org/issn/0092-8674", "issn-type": "print"}, {"issue": "6", "key": "6_16118258", "doi-asserted-by": "publisher", "first-page": "859", "DOI": "10.1016/0092-8674(95)90202-3", "volume": "83", "author": "Kastner", "year": "1995", "journal-title": "Cell", "ISSN": "http://id.crossref.org/issn/0092-8674", "issn-type": "print"}, {"issue": "6293", "key": "7_9191519", "doi-asserted-by": "publisher", "first-page": "558", "DOI": "10.1038/347558a0", "volume": "347", "author": "de Th\u00a0\u00a0", "year": "1990", "journal-title": "Nature; Physical Science (London)", "ISSN": "http://id.crossref.org/issn/1476-4687", "issn-type": "print"}, {"issue": "4976", "key": "8_9195457", "doi-asserted-by": "publisher", "first-page": "1577", "DOI": "10.1126/science.2218500", "volume": "249", "author": "Borrow", "year": "1990", "journal-title": "Science", "ISSN": "http://id.crossref.org/issn/0036-8075", "issn-type": "print"}, {"issue": "5", "key": "9_9409703", "doi-asserted-by": "publisher", "first-page": "1977", "DOI": "10.1073/pnas.88.5.1977", "volume": "88", "author": "Alcalay", "year": "1991", "journal-title": "PNAS", "ISSN": "http://id.crossref.org/issn/0027-8424", "issn-type": "print"}, {"issue": "4", "key": "10_9553663", "doi-asserted-by": "publisher", "first-page": "675", "DOI": "10.1016/0092-8674(91)90113-D", "volume": "66", "author": "de Th\u00a0\u00a0", "year": "1991", "journal-title": "Cell", "ISSN": "http://id.crossref.org/issn/0092-8674", "issn-type": "print"}, {"issue": "4", "key": "11_9553662", "doi-asserted-by": "publisher", "first-page": "663", "DOI": "10.1016/0092-8674(91)90112-C", "volume": "66", "author": "Kakizuka", "year": "1991", "journal-title": "Cell", "ISSN": "http://id.crossref.org/issn/0092-8674", "issn-type": "print"}, {"issue": "2", "key": "12_23308579", "first-page": "629", "volume": "11", "author": "Kastner", "year": "1992", "journal-title": "The EMBO Journal", "ISSN": "http://id.crossref.org/issn/0261-4189", "issn-type": "print"}, {"issue": "3", "key": "13_23309181", "first-page": "1161", "volume": "12", "author": "Chen", "year": "1993", "journal-title": "The EMBO Journal", "ISSN": "http://id.crossref.org/issn/0261-4189", "issn-type": "print"}, {"issue": "2", "key": "14_16163275", "first-page": "323", "volume": "12", "author": "Licht", "year": "1996", "journal-title": "Oncogene", "ISSN": "http://id.crossref.org/issn/0950-9232", "issn-type": "print"}, {"issue": "3", "key": "15_21324145", "first-page": "882", "volume": "87", "author": "Redner", "year": "1996", "journal-title": "Blood", "ISSN": "http://id.crossref.org/issn/0006-4971", "issn-type": "print"}, {"issue": "3", "key": "16_10268135", "doi-asserted-by": "publisher", "first-page": "177", "DOI": "10.1056/NEJM199307153290307", "volume": "329", "author": "Warrell", "year": "1993", "journal-title": "New England Journal of Medicine", "ISSN": "http://id.crossref.org/issn/0028-4793", "issn-type": "print"}, {"issue": "10", "key": "17_15632581", "first-page": "1615", "volume": "8", "author": "Lavau", "year": "1994", "journal-title": "Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K", "ISSN": "http://id.crossref.org/issn/0887-6924", "issn-type": "print"}, {"issue": "1", "key": "18_21321643", "first-page": "10", "volume": "83", "author": "Grignani", "year": "1994", "journal-title": "Blood", "ISSN": "http://id.crossref.org/issn/0006-4971", "issn-type": "print"}, {"issue": "11", "key": "19_23311068", "first-page": "2707", "volume": "15", "author": "Altabef", "year": "1996", "journal-title": "The EMBO Journal", "ISSN": "http://id.crossref.org/issn/0261-4189", "issn-type": "print"}, {"issue": "2", "key": "20_21325331", "first-page": "376", "volume": "89", "author": "Grisolano", "year": "1997", "journal-title": "Blood", "ISSN": "http://id.crossref.org/issn/0006-4971", "issn-type": "print"}, {"issue": "6", "key": "21_16721348", "doi-asserted-by": "publisher", "first-page": "2551", "DOI": "10.1073/pnas.94.6.2551", "volume": "94", "author": "Brown", "year": "1997", "journal-title": "PNAS", "ISSN": "http://id.crossref.org/issn/0027-8424", "issn-type": "print"}, {"key": "22_39507719", "ISSN": "http://id.crossref.org/issn/0950-9232", "issn-type": "print", "volume": "46", "first-page": "1547", "year": "1997", "journal-title": "Oncogene"}, {"issue": "8", "key": "23_23309367", "first-page": "3171", "volume": "12", "author": "Perez", "year": "1993", "journal-title": "The EMBO Journal", "ISSN": "http://id.crossref.org/issn/0261-4189", "issn-type": "print"}, {"issue": "16", "key": "24_15969872", "doi-asserted-by": "publisher", "first-page": "7401", "DOI": "10.1073/pnas.92.16.7401", "volume": "92", "author": "Jansen", "year": "1995", "journal-title": "PNAS", "ISSN": "http://id.crossref.org/issn/0027-8424", "issn-type": "print"}, {"issue": "3", "key": "25_14673487", "doi-asserted-by": "publisher", "first-page": "1178", "DOI": "10.1073/pnas.91.3.1178", "volume": "91", "author": "Chen", "year": "1994", "journal-title": "PNAS", "ISSN": "http://id.crossref.org/issn/0027-8424", "issn-type": "print"}, {"issue": "6548", "key": "26_16021160", "doi-asserted-by": "publisher", "first-page": "454", "DOI": "10.1038/377454a0", "volume": "377", "author": "Chen", "year": "1995", "journal-title": "Nature; Physical Science (London)", "ISSN": "http://id.crossref.org/issn/1476-4687", "issn-type": "print"}, {"issue": "6548", "key": "27_16021147", "doi-asserted-by": "publisher", "first-page": "397", "DOI": "10.1038/377397a0", "volume": "377", "author": "H\u00a0\u00a0rlein", "year": "1995", "journal-title": "Nature; Physical Science (London)", "ISSN": "http://id.crossref.org/issn/1476-4687", "issn-type": "print"}, {"issue": "6548", "key": "28_16021159", "doi-asserted-by": "publisher", "first-page": "451", "DOI": "10.1038/377451a0", "volume": "377", "author": "Kurokawa", "year": "1995", "journal-title": "Nature; Physical Science (London)", "ISSN": "http://id.crossref.org/issn/1476-4687", "issn-type": "print"}, {"issue": "7", "key": "29_16405811", "doi-asserted-by": "publisher", "first-page": "813", "DOI": "10.1210/me.10.7.813", "volume": "10", "author": "Sande", "year": "1996", "journal-title": "Molecular Endocrinology", "ISSN": "http://id.crossref.org/issn/0888-8809", "issn-type": "print"}, {"issue": "15", "key": "30_16354627", "doi-asserted-by": "publisher", "first-page": "7567", "DOI": "10.1073/pnas.93.15.7567", "volume": "93", "author": "Chen", "year": "1996", "journal-title": "PNAS", "ISSN": "http://id.crossref.org/issn/0027-8424", "issn-type": "print"}, {"issue": "10", "key": "31_16407912", "doi-asserted-by": "crossref", "first-page": "5458", "DOI": "10.1128/MCB.16.10.5458", "volume": "16", "author": "Zamir", "year": "1996", "journal-title": "Molecular and Cellular Biology", "ISSN": "http://id.crossref.org/issn/0270-7306", "issn-type": "print"}, {"issue": "12", "key": "32_16557290", "doi-asserted-by": "publisher", "first-page": "1646", "DOI": "10.1210/me.10.12.1646", "volume": "10", "author": "Seol", "year": "1996", "journal-title": "Molecular Endocrinology", "ISSN": "http://id.crossref.org/issn/0888-8809", "issn-type": "print"}, {"issue": "4", "key": "33_16738233", "doi-asserted-by": "publisher", "first-page": "470", "DOI": "10.1210/me.11.4.470", "volume": "11", "author": "Yoh", "year": "1997", "journal-title": "Molecular Endocrinology", "ISSN": "http://id.crossref.org/issn/0888-8809", "issn-type": "print"}, {"issue": "10", "key": "34_16485375", "doi-asserted-by": "publisher", "first-page": "1167", "DOI": "10.1210/me.10.10.1167", "volume": "10", "author": "Horwitz", "year": "1996", "journal-title": "Molecular Endocrinology", "ISSN": "http://id.crossref.org/issn/0888-8809", "issn-type": "print"}, {"issue": "2", "key": "35_9461856", "doi-asserted-by": "publisher", "first-page": "262", "DOI": "10.1016/0003-2697(91)90534-Z", "volume": "192", "author": "Guan", "year": "1991", "journal-title": "Analytical biochemistry", "ISSN": "http://id.crossref.org/issn/0003-2697", "issn-type": "print"}, {"issue": "8", "key": "37_16202186", "doi-asserted-by": "publisher", "first-page": "3624", "DOI": "10.1073/pnas.93.8.3624", "volume": "93", "author": "Dong", "year": "1996", "journal-title": "PNAS", "ISSN": "http://id.crossref.org/issn/0027-8424", "issn-type": "print"}, {"issue": "14", "key": "38_15658823", "doi-asserted-by": "publisher", "first-page": "1664", "DOI": "10.1101/gad.8.14.1664", "volume": "8", "author": "Bardwell", "year": "1994", "journal-title": "Genes &amp; Development", "ISSN": "http://id.crossref.org/issn/0890-9369", "issn-type": "print"}, {"issue": "6", "key": "39_15806283", "doi-asserted-by": "publisher", "first-page": "2249", "DOI": "10.1073/pnas.92.6.2249", "volume": "92", "author": "Cook", "year": "1995", "journal-title": "PNAS", "ISSN": "http://id.crossref.org/issn/0027-8424", "issn-type": "print"}, {"issue": "23", "key": "40_23311494", "first-page": "6701", "volume": "15", "author": "Le Douarin", "year": "1996", "journal-title": "The EMBO Journal", "ISSN": "http://id.crossref.org/issn/0261-4189", "issn-type": "print"}, {"issue": "6628", "key": "41_16770738", "doi-asserted-by": "publisher", "first-page": "16", "DOI": "10.1038/387016a0", "volume": "387", "author": "Wolffe", "year": "1997", "journal-title": "Nature; Physical Science (London)", "ISSN": "http://id.crossref.org/issn/1476-4687", "issn-type": "print"}, {"issue": "3", "key": "42_16780027", "doi-asserted-by": "publisher", "first-page": "325", "DOI": "10.1016/S0092-8674(00)80211-1", "volume": "89", "author": "Pazin", "year": "1997", "journal-title": "Cell", "ISSN": "http://id.crossref.org/issn/0092-8674", "issn-type": "print"}, {"issue": "12", "key": "43_16199560", "first-page": "1495", "volume": "6", "author": "Deweindt", "year": "1995", "journal-title": "Cell Growth &amp; Differentiation", "ISSN": "http://id.crossref.org/issn/1044-9523", "issn-type": "print"}, {"issue": "14", "key": "44_16296228", "doi-asserted-by": "publisher", "first-page": "6947", "DOI": "10.1073/pnas.93.14.6947", "volume": "93", "author": "Chang", "year": "1996", "journal-title": "PNAS", "ISSN": "http://id.crossref.org/issn/0027-8424", "issn-type": "print"}, {"issue": "11", "key": "45_16245454", "first-page": "2331", "volume": "12", "author": "Seyfert", "year": "1996", "journal-title": "Oncogene", "ISSN": "http://id.crossref.org/issn/0950-9232", "issn-type": "print"}, {"issue": "2", "key": "46_14676137", "first-page": "312", "volume": "8", "author": "Guidez", "year": "1994", "journal-title": "Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K", "ISSN": "http://id.crossref.org/issn/0887-6924", "issn-type": "print"}], "container-title": ["Proceedings of the National Academy of Sciences"], "language": "en", "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1073/pnas.94.17.9028", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 6, 15]], "date-time": "2017-06-15T06:32:56Z", "timestamp": 1497508376000}, "score": 28.855486, "issued": {"date-parts": [[1997, 8, 19]]}, "references-count": 45, "journal-issue": {"published-print": {"date-parts": [[1997, 8, 19]]}, "issue": "17"}, "URL": "http://dx.doi.org/10.1073/pnas.94.17.9028", "relation": {"cites": []}, "ISSN": ["0027-8424", "1091-6490"], "issn-type": [{"value": "0027-8424", "type": "print"}, {"value": "1091-6490", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T19:20:33Z", "timestamp": 1574536833729}, "reference-count": 26, "publisher": "Proceedings of the National Academy of Sciences", "issue": "33", "content-domain": {"domain": ["pnas.org"], "crossmark-restriction": true}, "short-container-title": ["Proceedings of the National Academy of Sciences"], "published-print": {"date-parts": [[2014, 8, 19]]}, "DOI": "10.1073/pnas.1412944111", "type": "journal-article", "created": {"date-parts": [[2014, 8, 5]], "date-time": "2014-08-05T06:19:13Z", "timestamp": 1407219553000}, "page": "12133-12138", "update-policy": "http://dx.doi.org/10.1073/pnas.cm10313", "source": "Crossref", "is-referenced-by-count": 14, "title": ["The PML domain of PML-RAR\u00a0 blocks senescence to promote leukemia"], "prefix": "10.1073", "volume": "111", "author": [{"given": "K.", "family": "Korf", "sequence": "first", "affiliation": []}, {"given": "H.", "family": "Wodrich", "sequence": "additional", "affiliation": []}, {"given": "A.", "family": "Haschke", "sequence": "additional", "affiliation": []}, {"given": "C.", "family": "Ocampo", "sequence": "additional", "affiliation": []}, {"given": "L.", "family": "Harder", "sequence": "additional", "affiliation": []}, {"given": "F.", "family": "Gieseke", "sequence": "additional", "affiliation": []}, {"given": "A.", "family": "Pollmann", "sequence": "additional", "affiliation": []}, {"given": "K.", "family": "Dierck", "sequence": "additional", "affiliation": []}, {"given": "S.", "family": "Prall", "sequence": "additional", "affiliation": []}, {"given": "H.", "family": "Staege", "sequence": "additional", "affiliation": []}, {"given": "H.", "family": "Ma", "sequence": "additional", "affiliation": []}, {"given": "M. A.", "family": "Horstmann", "sequence": "additional", "affiliation": []}, {"given": "R. M.", "family": "Evans", "sequence": "additional", "affiliation": []}, {"given": "T.", "family": "Sternsdorf", "sequence": "additional", "affiliation": []}], "member": "341", "published-online": {"date-parts": [[2014, 8, 4]]}, "reference": [{"issue": "2", "key": "1_21620118", "doi-asserted-by": "publisher", "first-page": "81", "DOI": "10.1016/j.ccr.2005.12.030", "volume": "9", "author": "Sternsdorf", "year": "2006", "journal-title": "Cancer cell", "ISSN": "http://id.crossref.org/issn/1535-6108", "issn-type": "print"}, {"key": "2_36914812", "doi-asserted-by": "publisher", "first-page": "219", "DOI": "10.1007/978-0-387-69259-3_13", "volume": "145", "author": "Grimwade", "year": "2010", "journal-title": "Cancer treatment and research", "ISSN": "http://id.crossref.org/issn/0927-3042", "issn-type": "print"}, {"issue": "10", "key": "3_17263623", "doi-asserted-by": "publisher", "first-page": "1927", "DOI": "10.1038/sj.leu.2402720", "volume": "16", "author": "Redner", "year": "2002", "journal-title": "Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K", "ISSN": "http://id.crossref.org/issn/0887-6924", "issn-type": "print"}, {"issue": "6149", "key": "4_14319924", "doi-asserted-by": "publisher", "first-page": "624", "DOI": "10.1038/330624a0", "volume": "330", "author": "Giguere", "year": "1987", "journal-title": "Nature", "ISSN": "http://id.crossref.org/issn/0028-0836", "issn-type": "print"}, {"issue": "3", "key": "5_6218129", "doi-asserted-by": "publisher", "first-page": "266", "DOI": "10.1038/3073", "volume": "20", "author": "Wang", "year": "1998", "journal-title": "Nature genetics", "ISSN": "http://id.crossref.org/issn/1061-4036", "issn-type": "print"}, {"issue": "16", "key": "6_10440723", "first-page": "2015", "volume": "14", "author": "Ferbeyre", "year": "2000", "journal-title": "Genes &amp; Development", "ISSN": "http://id.crossref.org/issn/0890-9369", "issn-type": "print"}, {"issue": "10", "key": "7_17263622", "doi-asserted-by": "publisher", "first-page": "1918", "DOI": "10.1038/sj.leu.2402722", "volume": "16", "author": "Ferbeyre", "year": "2002", "journal-title": "Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K", "ISSN": "http://id.crossref.org/issn/0887-6924", "issn-type": "print"}, {"key": "8_48369926", "ISSN": "http://id.crossref.org/issn/1078-8956", "issn-type": "print", "volume": "20", "first-page": "167", "year": "2014", "journal-title": "Nature medicine", "DOI": "10.1038/nm.3441", "doi-asserted-by": "crossref"}, {"issue": "6", "key": "9_10658695", "doi-asserted-by": "publisher", "first-page": "620", "DOI": "10.1006/bcmd.2000.0345", "volume": "26", "author": "Kogan", "year": "2000", "journal-title": "Blood cells, molecules &amp; diseases", "ISSN": "http://id.crossref.org/issn/1079-9796", "issn-type": "print"}, {"issue": "6", "key": "10_16721348", "doi-asserted-by": "publisher", "first-page": "2551", "DOI": "10.1073/pnas.94.6.2551", "volume": "94", "author": "Brown", "year": "1997", "journal-title": "PNAS", "ISSN": "http://id.crossref.org/issn/0027-8424", "issn-type": "print"}, {"issue": "2", "key": "11_14669713", "doi-asserted-by": "publisher", "first-page": "333", "DOI": "10.1016/0092-8674(94)90340-9", "volume": "76", "author": "Dyck", "year": "1994", "journal-title": "Cell", "ISSN": "http://id.crossref.org/issn/0092-8674", "issn-type": "print"}, {"key": "12_47633239", "ISSN": "http://id.crossref.org/issn/0261-4189", "issn-type": "print", "volume": "13", "first-page": "1073", "year": "1994", "journal-title": "The EMBO Journal", "DOI": "10.1002/j.1460-2075.1994.tb06356.x", "doi-asserted-by": "crossref"}, {"issue": "0", "key": "13_38470431", "doi-asserted-by": "publisher", "first-page": "27", "DOI": "10.1101/sqb.2010.75.008", "volume": "75", "year": "2010", "journal-title": "Cold Spring Harbor Symposia on Quantitative Biology", "ISSN": "http://id.crossref.org/issn/0091-7451", "issn-type": "print"}, {"issue": "8", "key": "14_18146399", "doi-asserted-by": "publisher", "first-page": "1163", "DOI": "10.1084/jem.20032226", "volume": "199", "year": "2004", "journal-title": "Journal of Experimental Medicine", "ISSN": "http://id.crossref.org/issn/0022-1007", "issn-type": "print"}, {"issue": "10", "key": "15_21326998", "first-page": "3780", "volume": "92", "author": "Pear", "year": "1998", "journal-title": "Blood", "ISSN": "http://id.crossref.org/issn/0006-4971", "issn-type": "print"}, {"issue": "8", "key": "16_21332401", "doi-asserted-by": "publisher", "first-page": "2989", "DOI": "10.1182/blood-2001-11-0089", "volume": "100", "year": "2002", "journal-title": "Blood", "ISSN": "http://id.crossref.org/issn/0006-4971", "issn-type": "print"}, {"issue": "1", "key": "17_18583257", "doi-asserted-by": "publisher", "first-page": "23", "DOI": "10.1128/MCB.25.1.23-33.2005", "volume": "25", "author": "Lane", "year": "2005", "journal-title": "Molecular and Cellular Biology", "ISSN": "http://id.crossref.org/issn/0270-7306", "issn-type": "print"}, {"key": "18_3790501", "doi-asserted-by": "publisher", "first-page": "585", "DOI": "10.1016/0014-4827(61)90192-6", "volume": "25", "author": "Hayflick", "year": "1961", "journal-title": "Experimental cell research", "ISSN": "http://id.crossref.org/issn/0014-4827", "issn-type": "print"}, {"issue": "10", "key": "19_17020517", "doi-asserted-by": "publisher", "first-page": "3497", "DOI": "10.1128/MCB.22.10.3497-3508.2002", "volume": "22", "author": "Ferbeyre", "year": "2002", "journal-title": "Molecular and Cellular Biology", "ISSN": "http://id.crossref.org/issn/0270-7306", "issn-type": "print"}, {"key": "20_48369927", "volume": "14", "first-page": "475", "year": "2009", "journal-title": "FRONT BIOSCI LANDMARK ED"}, {"issue": "13", "key": "21_46790056", "doi-asserted-by": "publisher", "first-page": "3358", "DOI": "10.1093/emboj/cdf341", "volume": "21", "author": "Bischof", "year": "2002", "journal-title": "The EMBO Journal", "ISSN": "http://id.crossref.org/issn/0261-4189", "issn-type": "print"}, {"issue": "13", "key": "22_16263825", "first-page": "2945", "volume": "56", "author": "Yoshida", "year": "1996", "journal-title": "Cancer Research", "ISSN": "http://id.crossref.org/issn/0008-5472", "issn-type": "print"}, {"issue": "6021", "key": "23_39015716", "doi-asserted-by": "publisher", "first-page": "1199", "DOI": "10.1126/science.1200609", "volume": "331", "year": "2011", "journal-title": "Science", "ISSN": "http://id.crossref.org/issn/0036-8075", "issn-type": "print"}, {"issue": "7384", "key": "24_41761963", "doi-asserted-by": "publisher", "first-page": "226", "DOI": "10.1038/nature10833", "volume": "482", "author": "Schwartzentruber", "year": "2012", "journal-title": "Nature", "ISSN": "http://id.crossref.org/issn/0028-0836", "issn-type": "print"}, {"issue": "2", "key": "25_29166862", "doi-asserted-by": "publisher", "first-page": "223", "DOI": "10.1016/j.cell.2007.07.003", "volume": "130", "author": "Collado", "year": "2007", "journal-title": "Cell", "ISSN": "http://id.crossref.org/issn/0092-8674", "issn-type": "print"}, {"issue": "5", "key": "26_39261535", "doi-asserted-by": "publisher", "first-page": "814", "DOI": "10.1038/leu.2011.18", "volume": "25", "author": "Occhionorelli", "year": "2011", "journal-title": "Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K", "ISSN": "http://id.crossref.org/issn/0887-6924", "issn-type": "print"}], "container-title": ["Proceedings of the National Academy of Sciences"], "language": "en", "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1073/pnas.1412944111", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 8, 13]], "date-time": "2019-08-13T15:19:38Z", "timestamp": 1565709578000}, "score": 28.697317, "issued": {"date-parts": [[2014, 8, 4]]}, "references-count": 26, "journal-issue": {"published-online": {"date-parts": [[2014, 8, 19]]}, "published-print": {"date-parts": [[2014, 8, 19]]}, "issue": "33"}, "URL": "http://dx.doi.org/10.1073/pnas.1412944111", "relation": {"cites": []}, "ISSN": ["0027-8424", "1091-6490"], "issn-type": [{"value": "0027-8424", "type": "print"}, {"value": "1091-6490", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 24]], "date-time": "2019-11-24T04:51:13Z", "timestamp": 1574571073928}, "reference-count": 0, "publisher": "INIST-CNRS", "issue": "1", "content-domain": {"domain": [], "crossmark-restriction": false}, "DOI": "10.4267/2042/55378", "type": "journal-article", "created": {"date-parts": [[2014, 12, 23]], "date-time": "2014-12-23T13:57:46Z", "timestamp": 1419343066000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["PML (promyelocytic leukemia)"], "prefix": "10.4267", "author": [{"given": "A", "family": "Rabellino", "sequence": "first", "affiliation": []}, {"given": "PP", "family": "Scaglioni", "sequence": "additional", "affiliation": []}], "member": "2793", "published-online": {"date-parts": [[2014, 12]]}, "container-title": ["Atlas of Genetics and Cytogenetics in Oncology and Haematology"], "deposited": {"date-parts": [[2014, 12, 23]], "date-time": "2014-12-23T13:57:59Z", "timestamp": 1419343079000}, "score": 27.297567, "issued": {"date-parts": [[2014, 12]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2014, 12]]}, "issue": "1"}, "URL": "http://dx.doi.org/10.4267/2042/55378", "ISSN": ["1768-3262"], "issn-type": [{"value": "1768-3262", "type": "electronic"}]}], "items-per-page": 20, "query": {"start-index": 0, "search-terms": null}}}